Document:

Exhibit 10.1

AMENDED AND RESTATED LOAN AGREEMENT

          THIS AMENDED AND RESTATED LOAN AGREEMENT (this “Agreement”) is made and entered into as of July 11, 2006, by and between FARO TECHNOLOGIES, INC., a Florida corporation (the “Borrower”), and SUNTRUST BANK, a Georgia banking corporation (the “Bank”). 

W I T N E S S E T H:

          WHEREAS, on September 17, 2003, Borrower and the Bank entered into a Loan Agreement, and the parties have amended the same from time to time between such date and the date of this Agreement; and

          WHEREAS, the parties now desire to further amend and to restate in its entirety the existing Loan Agreement in order to renew the Loans presently outstanding, to increase the amount of the Bank’s commitment, and to make the other changes as set forth in this Agreement, it being understood that this Agreement shall supersede in all respects the existing Loan Agreement between the parties;

          NOW, THEREFORE, the parties hereby agree as follows:

ARTICLE I 
 DEFINITIONS AND ACCOUNTING TERMS

          Section 1.01     Defined Terms.  As used in this Agreement, the following terms have the following meanings (terms defined in the singular to have the same meaning when used in the plural and vice versa):

          “Access Agreement” shall mean a waiver, subordination, bailee letter, mortgagee waiver, or other acknowledgment executed and delivered in favor of Bank by any landlord, warehouseman, processor, consignee, or other Person in possession of, having a Lien upon, or having rights or interests (including rights or interests arising by operation of law) in the Collateral, in each case in form and substance satisfactory to Bank.

          “Account Debtor” shall mean any Person that is or that may become obligated under, with respect to, or on account of, an Account.

          “Accounts” shall have the meaning set forth in the Security Agreement.

          “Acquisition” shall mean any transaction or series of related transactions that result, directly or indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of all or substantially all of any business or division of a Person, (b) the acquisition of in excess of 50% of the capital stock, partnership interests, membership interests, or equity of any Person, or otherwise causing a Person to become a Subsidiary, or (c) a merger or consolidation or any other business combination with another Person (other than a Person that is a Subsidiary) provided that Borrower or a Subsidiary is the surviving entity.

          “Advances” shall have the meaning set forth in Section 2.01.

          “Adjusted LIBOR” shall mean, with respect to each Interest Period for a Loan, the rate per annum, obtained by dividing (a) LIBOR for such Interest Period by (b) a percentage equal to 1.00 minus the Eurodollar Reserve Percentage.

           “Affiliate” shall mean, with respect to any Person, (a) any other Person which, directly or indirectly, controls, is controlled by or is under common control with, such Person, (b) any other Person which beneficially owns or holds, directly or indirectly, ten percent (10%) or more of any class of voting stock of such Person, or (c) any other Person, ten percent (10%) or more of any class of the voting stock (or if such other Person is not a corporation, ten percent (10%) or more of the equity interest) of which is beneficially owned or held, directly or indirectly, by such Person. The term control (including the terms “controlled by” and “under common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the Person in question.

          “Agreement” shall mean this Amended and Restated Loan Agreement, as amended, renewed, restated, supplemented, or modified from time to time.

          “Asset Sale” shall mean a sale, lease or sub-lease (as lessor or sublessor), sale and leaseback, assignment, conveyance, transfer or other disposition to, or any exchange of property with, any Person (other than Borrower or Guarantor), in one transaction or a series of transactions, of all or any material portion of Borrower’s or Guarantor’s businesses, assets or properties of any kind, whether real, personal, or mixed and whether tangible or intangible, whether now owned or hereafter acquired, other than (a) Inventory (as defined in the Security Agreement) sold or leased in the ordinary course of business, (b) disposal of obsolete or worn out Equipment (as defined in the Security Agreement) that Borrower deems no longer needed or useful in its business; or (c) licensing or cross-licensing of Borrower’s intellectual property rights; provided Borrower’s license or
cross-license of all or substantially all of its intellectual property rights shall constitute an “Asset Sale” hereunder.

          “Availability” shall mean as of any date of determination, (a) with respect to the Revolving Loan Commitment, $30,000,000 minus the sum of (i) all Advances then outstanding under the Revolving Loan Commitment, and (ii) the face amount of all issued and outstanding Letters of Credit, and (b) with respect to the Credit Card Funding Commitment, $100,000 minus all Advances then outstanding under the Credit Card Funding Commitment.

          “Bankruptcy Code” shall mean Title 11 of the United States Code (11 U.S.C. § 101 et seq.) as amended, modified, succeeded or replaced from time to time.

            “Business Day” shall mean any day other than a Saturday, Sunday, or other day on which commercial banks in Florida are authorized or required to close under the laws of the State of Florida, and if the applicable Business Day relates to any Loan, any day on which the London Inter-bank market is open for business.

          “Capital Lease” shall mean all leases that have been or should be capitalized on the books of the lessee in accordance with GAAP.

          “Change of Control” shall mean (a) any “person” or “group” (within the meaning of Sections 13(d) and 14(d) of the Exchange Act), becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 25%, or more, of the stock of Borrower having the right to vote for the election of members of the board of directors, or (b) a majority of the members of the board of directors do not constitute Continuing Directors, or (c) Borrower ceases to directly or indirectly own and control the majority of the outstanding capital stock of each of its Subsidiaries extant as of the Closing Date.

2

          “Closing Date” shall mean July 11, 2006.

          “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time, and the regulations and published interpretations thereof.

          “Collateral” shall mean (a) the Collateral as described in the Security Agreement, and (b) the Pledged Interests as defined in the Pledge Agreement, including the 65% equity interest in Holdco pledged to the Bank in the Pledge Agreement.

           “Collections” shall mean all cash, checks, notes, instruments and other items of payment (including insurance proceeds, proceeds of cash sales, rental proceeds and tax refunds).

          “Commitment” shall mean (a) the Revolving Loan Commitment, and (b) the Credit Card Funding Commitment.  

          “Consolidated EBITDA” shall mean, for Borrower and its Subsidiaries for any period, an amount equal to the sum of (a) Consolidated Net Income for such period, plus (b) to the extent deducted in determining Consolidated Net Income for such period, (i) Consolidated Interest Expense, (ii) income tax expense, (iii) depreciation and amortization expense, and (iv) all other non-cash charges determined on a consolidated basis in accordance with GAAP in each case for such period.

          “Consolidated Interest Expense” shall mean, for Borrower and its Subsidiaries for any period determined on a consolidated basis in accordance with GAAP, the sum of (a) total cash interest expense, including without limitation the interest component of any payments in respect of obligations under Capital Leases capitalized or expensed during such period (whether or not actually paid during such period) plus (b) the net amount payable (or minus the net amount receivable) under Hedge Agreements during such period (whether or not actually paid or received during such period).

          “Consolidated Net Income” shall mean, for any period, the net income (or loss) of Borrower, and its Subsidiaries for such period determined on a consolidated basis in accordance with GAAP, but excluding therefrom (to the extent otherwise included therein) (a) any extraordinary gains, (b) any gains attributable to write-ups of assets, (c) any equity interest of Borrower or any Subsidiary of Borrower in the unremitted earnings of any Person that is not a Subsidiary, and (d) any income (or loss) of any Person accrued prior to the date it becomes a Subsidiary or is merged into or consolidated with Borrower or any Subsidiary or the date such Person’s assets are acquired by Borrower or any Subsidiary; provided, that if Consolidated Net Income is negative in any fiscal quarter, the amount added for such fiscal quarter shall be zero and such negative Consolidated Net Income shall not
reduce the amount of Consolidated Net Income for any previous fiscal quarter.

3

          “Continuing Director” shall mean (a) any member of the board of directors who was a director of Borrower on the Closing Date, and (b) any individual who becomes a member of the board of directors after the Closing Date if such individual was appointed or nominated for election to the board of directors by a majority of the Continuing Directors, but excluding any such individual originally proposed for election in opposition to the board of directors in office at the Closing Date in an actual or threatened election contest relating to the election of the directors of Borrower (as such terms are used in Rule 14a-l 1 under the Exchange Act) and whose initial assumption of office resulted from such contest or the settlement thereof.

          “Credit Card Fees” shall have the meaning set forth in Section 2.04(d).  

           “Credit Card Funding Commitment” shall mean the Commitment of the Bank to make the Loans contemplated by Section 2.01(b) of this Agreement for the purpose of funding credit card transactions authorized on Borrower’s Credit Card Processing Network, with the aggregate principal amount of such Loans never to exceed $100,000.

          “Credit Card Loan” shall mean any Loan made to Borrower pursuant to the Credit Card Funding Commitment.

          “Credit Card Processing Network” shall mean the vendor that authorizes and captures credit card transactions for Borrower, and which presently is FDR.

          “Current Ratio” shall mean, as of any date of determination, the ratio of consolidated current assets of Borrower and its Subsidiaries to consolidated current liabilities of Borrower and its Subsidiaries, in each case as determined in accordance with GAAP.

           “Daily Balance” shall mean, with respect to each day during the term of this Agreement, the amount of an Obligation owed at the end of such day.

          “Default” shall mean any of the events specified in Section 7.01, whether or not any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.

          “Default Rate” shall mean the lesser of (a) five percent (5%) plus the otherwise applicable non-default interest rate hereunder, or (b) the maximum legal rate of interest that may be charged pursuant to Florida law.

           “Dividend” shall mean any direct or indirect patronage refund or distribution, dividend, redemption, return of capital, loan, advance, or other payment to any Person on account of any shares of stock of, securities of, or other ownership interest in, any other Person, including without limitation, any warrants or other rights or options to acquire shares of Stock of such other Person, but shall not include any share repurchases on the open market by Borrower.

          “Dollars” and the sign $ shall mean lawful money of the United States of America.

          “Domestic Subsidiary” shall mean a Subsidiary heretofore or hereafter formed and existing under the laws of the United States of America or any State thereof.

4

           “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time, and the regulations and published interpretations thereof.

          “Eurodollar Reserve Percentage” shall mean the aggregate of the maximum reserve percentages (including, without limitation, any emergency, supplemental, special or other marginal reserves) expressed as a decimal (rounded upwards to the next 1/100 of 1%) in effect on any day to which the Bank is subject with respect to the Adjusted LIBOR Rate pursuant to regulations issued by the Board of Governors of the Federal Reserve System (or any Governmental Authority succeeding to any of its principal functions) with respect to eurocurrency funding (currently referred to as “eurocurrency liabilities” under Regulation D). Loans shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to the Bank under Regulation D. The Eurodollar Reserve
Percentage shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.

          “Event of Default” shall mean any of the events specified in Section 7.01, provided that any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.

          “Foreign Subsidiary” shall mean a Subsidiary formed and existing under the laws of a country other than the United States of America or any State thereof.

          “GAAP” shall mean generally accepted accounting principles set forth in pronouncements of the Financial Accounting Standards Board, the Accounting Principles Board or the American Institute of Certified Public Accountants or which have other substantial authoritative support and are applicable in the circumstances as of the date of a report, as such principles are from time to time supplemented and amended.

          “Guarantor” or “Guarantors” shall mean, collectively, each of the Domestic Subsidiaries, together with each other Person that guarantees all or part of the Obligations hereunder after the Closing Date.

          “Guaranty” shall mean that certain Unlimited Continuing Guaranty Agreement dated as of September 17, 2003, as amended and reaffirmed on the date hereof, executed and delivered by Guarantors in favor of Bank, as the same may be further amended, restated, renewed, ratified, supplemented or otherwise modified from time to time, together with any other Unlimited Continuing Guaranty Agreement delivered by a Guarantor in favor of Bank after the Closing Date.

           “Hedge Agreements” shall mean, collectively, any rate swap transaction, basis swap, forward rate transaction, commodity swap, commodity option, equity or equity index option, bond option, interest rate option, foreign exchange transaction, short sale transaction, cap transaction, floor transaction, collar transaction, currency swap transaction, cross currency rate swap transaction, currency option, any other similar transaction (including any option with respect to any of these transactions) and any combination of the foregoing which directly hedges or offsets interest rate risk or other market risk with respect to any of the obligations of Borrower under the Loan Documents, Borrower or any of its Subsidiaries at the time such transaction is entered into.

5

          “Holdco” shall mean Faro Cayman, LP, a limited partnership formed and existing under the laws of the Cayman Islands and a Foreign Subsidiary of Borrower in which Borrower and Faro Delaware, Inc. own 100% of the equity interests and which, together with Borrower, in turn owns 100% of all of the other Foreign Subsidiaries.  Pursuant to the Pledge Agreement Borrower is pledging 65% of such equity interests in Holdco to Bank as collateral security for the Obligations.

          “Indebtedness” of any Person shall mean, without duplication (a) all obligations of such Person for borrowed money of any kind, now existing or hereafter arising whether primary, secondary, direct, contingent or otherwise, (b) all obligations of such Person for all issued and outstanding Letters of Credit; (c) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (d) all obligations of such Person in respect of the deferred purchase price of property or services (including trade payables incurred in the ordinary course of business; (e) all obligations of such Person under any conditional sale or other title retention agreement(s) relating to property acquired by such Person, (f) all obligations under such Person’s Capital Leases, (g) all obligations, contingent or otherwise, of such Person in respect of letters of credit, acceptances or
similar extensions of credit, (h) all guarantees of such Person of the type of Indebtedness described in clauses (a) through (g) above, (i) all Indebtedness of a third party secured by any Lien on property owned by such Person, whether or not such Indebtedness has been assumed by such Person, (j) all obligations of such Person, contingent or otherwise, to purchase, redeem, retire or otherwise acquire for value any common stock of such Person, and (k) off-balance sheet liabilities of such Person. The Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture in which such Person is a general partner or a joint venturer, except to the extent that the terms of such Indebtedness provide that such Person is not liable therefor.

          “Insolvency Proceeding” shall mean any proceeding commenced by or against any Person under any provision of the Bankruptcy Code or under any other state or federal bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal moratoria, compositions, extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief.

          “Intercompany Subordination Agreement” shall mean that certain Intercompany Subordination Agreement dated as of September 17, 2003 by and among Borrower and its Subsidiaries in favor of Bank, as reaffirmed as of the date hereof and as further amended, restated, renewed, supplemented or otherwise modified from time to time.

          “Interest Period” shall mean with respect to any Loan, the period commencing on the date as Borrower initially selects, and ending on the numerically corresponding day in the first calendar month thereafter, except that each such Interest Period that commences on the last Business Day of a calendar month (or on any day for which there is no numerically corresponding day in the appropriate subsequent calendar month) shall end on the last Business Day of the appropriate subsequent calendar month. No Interest Period may extend beyond the Maturity Date. If an Interest Period would end on a day that is not a Business Day, such Interest Period shall be extended to the next Business Day unless such Business Day would fall in the next calendar month, in which event such Interest Period shall end on the immediately preceding Business Day.

6

          “Inventory” shall have the meaning set forth in the Security Agreement.

          “L/C Cash Collateral Account” shall have the meaning set forth in Section 7.03.

          “L/C Related Documents” shall have the meaning set forth in Section 2.18(f)(i).

          “Letter of Credit” shall mean any standby, documentary or trade Letter of Credit issued by Bank hereunder as requested by Borrower for the account or to secure obligations of Borrower or a Subsidiary of Borrower, in accordance with the terms of Section 2.18.

          “Letter of Credit Documents” shall mean, with respect to any Letter of Credit, such Letter of Credit, any amendments thereto, any documents delivered in connection therewith, any application therefor, and any agreements, instruments, guarantees or other documents (whether general in application or applicable only to such Letter of Credit) governing or providing for (a) the rights and obligations of the parties concerned or at risk or (b) any collateral security for such obligations.

          “Letter of Credit Fees” shall have the meaning set forth in Section 2.04.

          “Letter of Credit Obligations” shall mean, at any time, the sum of (a) the maximum amount that is, or at any time thereafter may become, available to be drawn under Letters of Credit then outstanding, assuming compliance with all requirements for drawings referred to in such Letters of Credit plus (b) the aggregate amount of all drawings under Letters of Credit honored by Bank but not theretofore reimbursed.

          “Letter of Credit Sublimit” shall mean an aggregate amount not to exceed $1,000,000, as such amount may be reduced from time to time in accordance with the provisions hereof.

          “LIBOR” shall mean for any applicable Interest Period with respect to a Loan, the rate per annum for deposits in U.S. dollars for a period equal to such Interest Period appearing on the display designated as Page 3750 on the Dow Jones Markets Service (or such other page on that service or such other service designated by the British Bankers’ Association for the display of such Association’s Interest Settlement Rates for U. S. dollar deposits), as of 11:00 A.M. (London, England time) on the day that is two (2) Business Days prior to the first day of the Interest Period or if such Page 3750 is unavailable for any reason at such time, the rate which appears on the Reuters Screen IDA Page as of such date and such time; provided, that if the Bank determines that the relevant foregoing sources are unavailable for the relevant Interest Period, LIBOR shall mean the rate of interest
determined by the Bank to be the average (rounded upwards, if necessary, to the nearest 1/100th of 1 %) of the rates per annum at which deposits in U.S. dollars are offered by the Bank two (2) Business Days preceding the first day of such Interest Period to leading banks in the London interbank market as of 10:00 A.M. (Orlando, Florida time) for delivery on the first day of such Interest Period, for the number of days comprised therein and in an amount comparable to the amount of such Loan.

7

           “Lien” shall mean any mortgage, deed of trust, leasehold mortgage, pledge, security interest, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or other), or preference, priority, or other security agreement or preferential arrangement, charge, or encumbrance of any kind or nature whatsoever (including, without limitation, any conditional sale or other title retention agreement, any financing lease having substantially the same economic effect as any of the foregoing, and the filing of any financing statement under the Uniform Commercial Code or comparable law of any jurisdiction to evidence any of the foregoing).

          “Loan” shall have the meaning set forth in Section 2.01.

          “Loan Documents” shall mean this Agreement, the Note, the Intercompany Subordination Agreement, the Letter of Credit Documents, the Security Agreement, the Pledge Agreement, the Tax Indemnity Agreement, the Lockbox Account Agreement, any Hedge Agreement entered into by and between Borrower and Bank with respect to the Loans, and all other agreements, instruments, and documents executed in connection with any of the foregoing, now or hereafter evidencing, securing, guaranteeing or otherwise relating to the Obligations or the Collateral.

           “Lockbox Account” shall mean each blocked bank account or bank account associated with a lock-box, into which the funds of Borrower (including, without limitation, proceeds of the Collateral) are deposited or credited, and which is maintained in the name of Bank or Borrower, as the Bank may determine, on terms acceptable to the Bank.

          “Lockbox Account Agreement” shall mean that certain SunTrust Treasury Management Services Master Agreement (including, without limitation, the Wholesale Lockbox Service Schedule thereto) executed and delivered by Borrower in favor of Bank, regarding the operation of the Lockbox Account, as the same may from time to time be amended, supplemented or modified.

          “Material Adverse Effect” shall mean a material adverse effect on (a) the business, assets, operations, prospects or financial or other condition of Borrower, (b) Borrower’s ability to pay any of the Obligations in accordance with the terms of this Agreement, (c) the Collateral or Bank’s Liens on the Collateral or the priority of such Liens, (d) Bank’s rights and remedies under the Agreement and the other Loan Documents, or (e) any Guarantor’s ability to honor its payment or performance obligations pursuant to a Guaranty.

          “Maturity Date” shall mean the earlier to occur of (a) demand for full payment of the Obligations by Bank following the occurrence and continuation of an Event of Default under this Agreement or any other Loan Document (in the case of any Event of Default, subject to any applicable cure periods provided therein), or (b) April 30, 2009.

          “Multi-Employer Plan” shall mean a Plan described in Section 4001(a)(3) of ERISA.

          “Net Cash Proceeds” shall mean, with respect to any Asset Sale, the aggregate amount of cash received from time to time by or on behalf of such Person in connection with such transaction, after deducting therefrom only (a) reasonable and customary brokerage commissions, underwriting fees and discounts, legal fees, finder’s fees and other similar fees and commissions, in each case to the extent, but only to the extent, that the amounts so deducted are, at the time of receipt of such cash, actually paid to a Person that is not an Affiliate and are properly attributable to such transaction, and (b) the amount of taxes payable in connection with or as a result of such transaction.

8

          “Note” shall have the meaning set forth in Section 2.03 of this Agreement.

          “Notice of Request for Letter of Credit” shall mean a notice of request for issuance of a Letter of Credit in form and substance satisfactory to Bank.

          “Obligations” shall mean all present and future loans, advances, liabilities, obligations, covenants, duties, and Indebtedness owing by Borrower to the Bank, including, without limitation of all Indebtedness arising under this Agreement (including Letter of Credit Obligations) and the other Loan Documents, whether or not evidenced by any note, or other instrument or document, whether arising from an extension of credit, issuance of a letter of credit, acceptance, loan, guaranty, Hedge Agreement indemnification or otherwise, whether direct or indirect (including, without limitation, those acquired by assignment from others, and any participation by the Bank in Borrower’s debts owing to others), absolute or contingent, due or to become due, primary or secondary, as principal or guarantor, and including, without limitation, all interest, charges, expenses, fees, attorneys’ fees,
filing fees and any other sums chargeable to Borrower under this Agreement, under any other Loan Document, or under any other agreement or instrument with the Bank. Any reference in this Agreement or the Loan Documents to the Obligations shall include all amendments, changes, extensions, modifications, renewals, replacements, substitutions, and supplements thereto and thereof, as applicable, both prior and subsequent to any Insolvency Proceeding.

          “Organizational Documents” shall mean, for any Person, such Person’s (a) articles or certificate of incorporation, formation or organization, (b) bylaws, operating agreement or other similar document, (c) certificate of determination or instrument relating to the rights of preferred shareholders, members or other equity holders of such Person, and (d) shareholder rights agreement or other similar agreement.

           “PBGC” shall mean the Pension Benefit Guaranty Corporation or any entity succeeding to any or all of its functions under ERISA.

          “Patriot Act” shall have the meaning set forth in Section 8.21 of this Agreement.

          “Permitted Acquisition” shall mean any Acquisition by Borrower or a Subsidiary which satisfies each of the following requirements: 

          (a)  no Event of Default has occurred and is continuing or will result from, such Acquisition; 

          (b)  if the aggregate consideration to be paid by Borrower and its Subsidiaries in connection with such Acquisition (including debt Assumed, but excluding capital stock of Borrower) exceeds $10,000,000, Borrower shall have delivered to the Bank a certificate demonstrating that, after giving effect to such Acquisition, Borrower shall be in pro forma compliance with Section 5.13;  and

9

          (c)  if the Subsidiary so acquired is a Domestic Subsidiary, Borrower also complies with Section 6.03.

          “Permitted Asset Sale” shall mean any Asset Sale by Borrower or a Subsidiary which satisfies each of the following requirements: (a) no Event of Default has occurred and is continuing, or will result from, such Asset Sale; (b) if the aggregate consideration to be received by Borrower and its Subsidiaries in connection with such Asset Sale (including debt of the and capital stock of the purchaser) exceeds $2,500,000, Borrower shall have delivered to the Bank a certificate demonstrating that, after giving effect to such Asset Sale, Borrower shall be in pro forma compliance with Section 5.13.

          “Permitted Indebtedness” shall mean (a) Indebtedness evidenced by this Agreement and the Note, (b) accounts payable to trade creditors for goods or services which are not (1) in the aggregate amount of more than $750,000, and (2) aged more than ninety (90) days from the billing date, incurred in the ordinary course of business, as such business is presently conducted, unless contested in good faith and by appropriate proceedings (c) current operating liabilities (other than for borrowed money) which are not more than thirty (30) days past due, incurred in the ordinary course of business, as such business is presently conducted, and paid within the specified time, unless contested in good faith and by appropriate proceedings, (d) Indebtedness secured by Permitted Liens; (e) Indebtedness outstanding on the Closing Date as set forth on Borrower’s financial statements described in
Section 4.05; and (f) other unsecured Indebtedness in an aggregate amount outstanding at any time not in excess of $1,000,000.

          “Permitted Liens” shall mean (a) Liens in favor of Bank, (b) Liens for taxes or assessments or other government charges or levies if not yet due and payable or, if due and payable, if they are being contested in good faith by appropriate proceedings and for which appropriate reserves are maintained; (c) purchase money security interests perfected in accordance with applicable law, but, with respect to any purchase money security interest perfected after the date of this Agreement, only if the Bank shall have specifically approved in writing the incurrence of the Indebtedness secured by such purchase money security interest, (d) Liens reflected by Uniform Commercial Code financing statements filed in respect of Capital Leases permitted hereunder (it being agreed that no new Capital Lease shall be permitted after the date of this Agreement without the Bank’s prior written consent)
and true leases of Borrower and its Subsidiaries; (e) Liens imposed by the operation of law, such as mechanics’, materialmen’s, landlords’, warehousemen’s, and carriers’ Liens, and other similar Liens, securing obligations incurred in the ordinary course of business which are not past due for more than thirty (30) days or which are being contested in good faith by appropriate proceedings and for which appropriate reserves have been established by Bank; (f) other Liens approved by Bank in writing; and (g) Liens under workers’ compensation, unemployment insurance, Social Security, or similar legislation; and easements, rights-of-way, restrictions, and other similar encumbrances which, in the aggregate, do not materially interfere with the occupation, use, and enjoyment by Borrower or any Subsidiary of the property or assets encumbered thereby in the normal course of its business or materially impair the value of the property subject thereto.

10

           “Person” shall mean an individual, partnership, corporation, business trust, joint stock company, trust, unincorporated association, joint venture, governmental authority, or other entity of whatever nature.

          “Plan” shall mean any pension plan which is covered by Title IV of ERISA and in respect of which Borrower is an “employer” as defined in Section 3(5) of ERISA.

          “Pledge Agreement” shall mean, individually or collectively, any Pledge Agreement executed and delivered by Borrower in favor of Bank, wherein Borrower has granted to Bank a security interest in and pledge of, (a) 65% of the stock or other equity interests owned by Borrower in Holdco, and (b) 100% of the stock or other equity interests owned by Borrower in each Domestic Subsidiary, as the same may be ratified, amended, restated, renewed, supplemented or otherwise modified from time to time.  The original Pledge Agreement was executed and delivered on September 17, 2003 and is being reaffirmed as of the date hereof.

          “Principal Office” shall mean Bank’s office at 200 South Orange Avenue, Orlando, Florida 32801.

          “Prohibited Transaction” shall mean any transaction set forth in Section 406 of ERISA or Section 4975 of the Code.

          “Reaffirmation of Original Loan Documents” shall have the meaning set forth in Section 3.01(a)(vi) of this Agreement.

          “Reportable Event” shall mean any of the events set forth in Section 4043 of ERISA.

          “Revolving Loan” shall mean any Loan made to Borrower pursuant to the Revolving Loan Commitment.

          “Revolving Loan Commitment” shall mean the Commitment of the Bank to make the Loans contemplated by Section 2.01(a) of this Agreement and to issue any related Letter of Credit in accordance with Section 2.18, with the aggregate principal amount of such Loans (including the aggregate face amount of all outstanding Letters of Credit) never to exceed $30,000,000.

          “Security Agreement” shall mean that certain Security Agreement dated of even date herewith executed and delivered by Borrower and each Domestic Subsidiary in favor of Bank, as amended, restated, renewed, supplemented or otherwise modified from time to time.

          “Senior Funded Debt” shall mean, at any date of calculation, (a) all Indebtedness of Borrower to the Bank, plus (b) all other interest-bearing liabilities of Borrower, plus (c) all Capital Leases of Borrowers.

          “Solvent” shall mean, at any date of determination (a) the assets of such Person, at a fair valuation, are in excess of the total amount of its debts (including contingent liabilities), and (b) the present fair saleable value of its assets is greater than its probable liability on its existing debts as such debts become absolute and matured, and (c) it is then able and expects to be able to pay its debts (including contingent debts and other commitments) as they mature, and (d) it has capital sufficient to carry on its business as conducted and as proposed by the Borrower to be conducted.

11

          “Subsidiary” shall mean, with respect to any Person, any corporation of which more than thirty-five percent (35%) of the outstanding securities of any class or classes, the holders of which are ordinarily, in the absence of contingencies, entitled to elect a majority of the corporate directors (or Persons performing similar functions), is at the time, directly or indirectly through one or more intermediaries, owned by such Person or one or more of its Subsidiaries (including, without limitation, each of the Foreign Subsidiaries and the Domestic Subsidiaries).

           “Tax Indemnity Agreement” shall mean that certain Tax Indemnity Agreement dated of September 17, 2003 executed and delivered by Borrower in favor of Bank and reaffirmed by Borrower as of the date hereof, as the same may be further ratified, amended, restated, renewed, supplemented or otherwise modified from time to time.

          Section 1.02     Accounting Terms.  All accounting terms not specifically defined herein shall be construed in accordance with GAAP on a consistent basis; provided, that if Borrower notifies the Bank that Borrower desires to amend any covenant in Section 5.13 (or any related definition) to eliminate the effect of any change in GAAP on the operation of such covenant (or any related definition), or the Bank notifies Borrower that the Bank desires to amend any such covenant (or any related definition) for such purpose, then Borrower’s compliance which such covenant shall be determined (or such definition shall be interpreted) on the basis of GAAP as in effect immediately before such change became effective, until either such notice is withdrawn or such covenant (or such definition) is amended in a manner satisfactory to Borrower and the Bank.

ARTICLE II 
 AMOUNT AND TERMS OF THE LOAN

          Section 2.01     The Loans.  Bank agrees on the terms and conditions hereinafter set forth, to make advances (the “Advances” and each an individual “Advance”) to Borrower from time to time during the period from the date of this Agreement (the “Loan” or “Loans”) up to, but not including, the Maturity Date, as follows:

          (a)     Revolving Loan.  Until the Maturity Date, Borrower may borrow from Bank in respect of the Revolving Loan Commitment amounts not to exceed at any time outstanding, the lesser of (a) the Availability under the Revolving Loan Commitment, or (b) the maximum amount of the Revolving Loan Commitment. Until the Maturity Date, Borrower may borrow, repay and reborrow under this Section 2.01(a).  The face amount of all outstanding Letters of Credit issued pursuant to Section 2.18 of this Agreement also shall count against the Revolving Loan Commitment.

          (b)     Credit Card Funding Commitment.  Until the Maturity Date, Borrower may borrow from Bank in respect Credit Card Funding Commitment amounts not to exceed at any time outstanding, the lesser of (a) the Availability under the Credit Card Funding Commitment, or (b) the maximum amount of the Credit Card Funding Commitment. Until the Maturity Date, Borrower may borrow, repay and reborrow under this Section 2.01(b). 

12

          Section 2.02     Notice and Manner of Borrowing for Loans.  Borrower shall request each borrowing under the Loan by written or telegraphic notice (effective upon receipt) not later than 11:00 a.m. (Eastern time) not less than two (2) Business Days prior to any proposed Loan, specifying (i) the date of such Loan, (ii) the amount of such Loan, and (iii) the duration of the Interest Period applicable thereto. On the date of such Loan and immediately upon fulfillment of all applicable conditions set forth in Article III, Bank will make the proceeds of such Loan available to Borrower by crediting the amount thereon to Borrower’s account with Bank. Each borrowing request shall be irrevocable and binding on Borrower and Borrower shall indemnify Bank for any loss or expense incurred by Bank as a result of the failure to borrow as specified in such
request.

          Section 2.03     The Note.  Borrower’s obligation to repay the Revolving Loans shall be evidenced by a single promissory note (the “Note”) in substantially the form of Exhibit A attached hereto, payable to the order of Bank.  Borrower’s obligations to Bank in respect of amounts advanced under the Credit Card Funding Commitment shall not be evidenced by the Note, but rather shall be evidenced by the Bank’s customary credit card agreement.

          Section 2.04     Fees.  Borrower shall pay to Bank the following fees and charges, which fees shall be non-refundable and fully earned when paid (irrespective of whether this Agreement is terminated thereafter):

          (a)     Commitment Fee.  At or before the Closing Date, Borrower shall pay Bank in respect of the Revolving Loan Commitment a commitment fee in the amount of 0.25% of the Revolving Loan Commitment (i.e. $75,000).

          (b)     Unused Line Fee. On the last day of each month in arrears during the term of this Agreement, an unused line fee in an amount equal to 0.25% per annum times the result of (a) the Revolving Loan Commitment, less (b) the average Daily Balance of the Loans that were outstanding under the Revolving Loan Commitment during the immediately preceding month.

          (c)     Letter of Credit Fees. For each Letter of Credit issued by Bank hereunder, Borrower shall pay to Bank, on demand, its standard fees in effect at such time for the issuance of such Letter of Credit or incurrence of such fee or expense in connection with such Letter of Credit (including, without limitation, any issuance, renewal, conversion, or drawing fees) (the “Letter of Credit Fees”).

          (d)     Credit Card Funding Fee. Borrower shall pay to Bank, on demand, its standard credit card fees for funding and services similar to those that the Bank is providing Borrower under the Credit Card Funding Commitment (the “Credit Card Fees”).

          Section 2.05     Interest Rate for Loans.  

          (a)     Revolving Loans. Borrower shall pay interest to Bank on the unpaid principal amount of the Revolving Loans (including Revolving Loans resulting from any drawing on a Letter of Credit) at a rate per annum equal to the Adjusted LIBOR rate, plus 1.75%. 

          (b)     Credit Card Loans.  Borrower shall pay interest to the Bank on the unpaid principal amount of Credit Card Loans at the standard rate the Bank normally charges its customers for credit card loans and services similar to those being provided by the Bank under this Agreement. 

13

          (c)     Calculation of Interest.  Interest on all Loans shall be calculated on the basis of a year of three hundred sixty (360) day year for the actual number of days elapsed.

          Section 2.06     Savings Clause.  Notwithstanding anything contained herein to the contrary, the interest rate charged pursuant to this Agreement including all charges and fees in connection therewith deemed in the nature of interest under Florida law, shall not exceed the maximum rate allowed by law. In the event the stated interest rate on the Notes together with any other charge or fee deemed in the nature of interest exceeds the maximum legal rate, then, ipso facto, the interest rate shall be reduced to the maximum legal rate, and if, interest in excess of the maximum legal rate shall have been paid by Borrower in connection with this Agreement or under the Notes, the amount of such excess shall be applied to unpaid and outstanding principal, and not to the payment of interest.

          Section 2.07     Interest Payments on Loans.  Interest on the Loans shall be paid to Bank in immediately available funds, on the last day of each month in arrears, and on the Maturity Date.

          Section 2.08     Late Payments and Default Rate.  Borrower shall pay to Bank a late charge equal to five percent (5.0%) of the installment (or a portion thereof) on the Note that is not paid within five (5) days of the due date. All late charges shall be immediately paid by Borrower to Bank. This late payment charge serves to defray a part of the increased cost of collection and is not a penalty, but is in addition to any interest which may be imposed at the default rate as a result of failure to pay within the grace period and any other remedies which are or may become exercisable by Bank hereunder. Upon an Event of Default, any unpaid portion of the principal, all accrued and unpaid interest and any other sums due under any Notes shall bear interest at the Default Rate from the date of such Event of Default and shall accrue until the earlier to occur of (a)
waiver in writing by Bank of the applicable Event of Default, (b) agreement by Bank to rescind the charging of interest at the Default Rate, or (c) payment in full of the Obligations.

          Section 2.09     Optional Prepayments.  Borrower may, upon at least two (2) Business Days’ notice to Bank, prepay Loans in whole or in part on the last day of the Interest Period for such Loans, with accrued interest to the date of such prepayment on the amount prepaid.

          Section 2.10     Mandatory Repayments.  

          (a)     Asset Sales.  Immediately upon the receipt by Borrower of the Net Cash Proceeds of any Asset Sale, Borrower shall prepay the Loans in an amount equal to all of such Net Cash Proceeds.

          (b)     Credit Card Funding and Letters of Credit.  Borrower shall, upon Bank’s written demand therefor, repay any Advance outstanding under (i) the Credit Card Funding Commitment, and (ii) the Revolving Commitment as a consequence (and solely as a consequence) of any drawing under a Letter of Credit.  Any prepayment pursuant to this Section 2.10 shall be applied to the Obligations in accordance with Section 2.12.

14

          Section 2.11     Method of Payment.  Borrower shall make each payment on the due date therefor, not later than 2:00 p.m. (Eastern Time) in lawful money of the United States to Bank at its Principal Office in immediately available funds. Any payment received by Bank later than 2:00 p.m. (Eastern Time), or on a day that is not a Business Day shall be deemed to have been received on the following Business Day, and any applicable interest and fees shall continue to accrue until such Business Day. Borrower hereby authorizes Bank, if and to the extent payment is not made when due under this Agreement, from time to time, to charge such amounts to any account of Borrower maintained with Bank. Borrower agrees to pay all payments due to Bank under this Agreement, whether for principal, interest, fees or otherwise, without set-off or counterclaim, and free and clear and
without any deduction or withholding on account of any taxes, all of which shall be for the account of Borrower and paid by it directly to the relevant taxing or other authority when due. If Borrower shall be required by law to make any deduction or withholding in respect of taxes from any payment hereunder, the sum payable shall be increased by such amount as will result in the receipt by Bank, after such deduction or withholding, of the amount that would have been received if such deduction or withholding had not been required.

          Section 2.12     Application of Payments.  Until the occurrence and continuation of an Event of Default, all Payments made to Bank (other than those payments that relate to specific fees, or payments required by this Agreement to be applied to specific Obligations), and the proceeds of the Collateral shall be applied first, to pay fees and expenses of Bank in connection with this Agreement until paid in full, second, to pay interest due in respect of the Loan until paid in full, third, to pay the principal of all Loans until paid in full, fourth, after the occurrence and during the continuance of an Event of Default hereunder, to cash collateralize the Letter of Credit Obligations in the amount of 105% of the outstanding face amount of any Letters of Credit, and fifth, to all other Obligations to the extent not paid in full, and thereafter, to Borrower. After
the occurrence and during the continuation of an Event of Default, all payments made to Bank shall be applied to the Obligations in Bank’s sole discretion.

          Section 2.13     Demand, Maturity Date.  Notwithstanding anything herein to the contrary, all outstanding principal, interest and other amounts due under this Agreement in respect of the Obligations shall be due and payable in full, without demand on the Maturity Date.

          Section 2.14     Use of Proceeds.  

          (a)     In General.  The proceeds of the Loans hereunder shall be used by Borrower to finance working capital needs and for other general corporate purposes. Notwithstanding the foregoing, Borrower will not used the proceeds of the Loans hereunder in order to finance any Acquisition for a gross purchase price of $10,000,000 or more without the prior written consent of the Bank.  

          (b)     Margin Stock.  Borrower will not, directly or indirectly, use any part of such proceeds for the purpose of purchasing or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System, to extend credit to any Person for the purpose of purchasing or carrying any such margin stock, or for any purpose which violates, or is inconsistent with, Regulation X of such Board of Governors, or Executive Order 13224.

15

          Section 2.15     Illegality.  Notwithstanding any other provision in this Agreement to the contrary, if Bank determines that any applicable law, rule, or regulation, or any change therein, or any change in the interpretation or administration thereof by any governmental authority, central bank, or comparable agency charged with the interpretation or administration thereof, or compliance by Bank with any request or directive (whether or not having the force of law) of any such authority, central bank, or comparable agency shall make it unlawful or impossible for Bank to maintain or fund Loans, then upon notice to Borrower by Bank the outstanding principal amount of the Loans, together with interest accrued thereon, and any other amounts payable to Bank under this Agreement shall at the option of Bank either be (a) repaid immediately upon demand of Bank if such
change or compliance with such request, in the judgment of Bank, requires immediate repayment, or (b) repaid at the expiration of the last Interest Period to expire before the effective date of any such change or request.

          Section 2.16     Increased Cost.  Borrower shall pay to Bank from time to time such amounts as Bank may determine to be necessary to compensate Bank for any costs incurred by Bank which Bank determines are attributable to its making or maintaining any Loans hereunder or its obligation to convert to such Loans hereunder, or any reduction in any amount receivable by Bank under this Agreement or the Notes in respect of any such Loans or such obligation (such increases in costs and reductions in amounts receivable being herein called “Additional Costs”), resulting from any change after the date of this Agreement in U.S. federal, state, municipal, or foreign laws or regulations (including Regulation D), or the adoption or making after such date of any interpretations, directives, or requirements applying to a class of banks including Bank of or under
any U.S. federal, state, municipal, or any foreign laws or regulations (whether or not having the force of law) by any court or governmental or monetary authority charged with the interpretation or administration thereof (“Regulatory Change”), which (a) changes the basis of taxation of any amounts payable to Bank under this Agreement or the Notes in respect of any of such Loan (other than taxes imposed on the overall net income of Bank or of its Lending Office for any of such Loans by the jurisdiction where the Principal Office or such Lending Office is located), (b) imposes or modifies any reserve, special deposit, compulsory loan, or similar requirements relating to any extensions of credit or other assets of, or any deposits with or other liabilities of, Bank (including any of such Loans or any deposits referred to in the definition of LIBOR), or (c) imposes any other condition affecting this Agreement or the Notes (or any of such extensions of credit or liabilities). Bank will
notify Borrower of any event occurring after the date of this Agreement which will entitle Bank to compensation pursuant to this Section as promptly as practicable after it obtains knowledge thereof and determines to request such compensation, and shall provide to Borrower therewith a statement setting forth the basis for, and a calculation in reasonable detail of the additional amounts to be paid to the Bank hereunder. Determinations by Bank for purposes of this Section of the effect of any Regulatory Change on its costs of making or maintaining Loans or on amounts receivable by it in respect of Loans, and of the additional amounts required to compensate Bank in respect of any Additional Costs, shall be conclusive, provided that such determinations are made on a reasonable basis.

          Section 2.17     Funding Loss Indemnification.  Borrower shall pay to Bank, upon the request of Bank, such amount or amounts as shall be sufficient (in the reasonable opinion of Bank) to compensate it for any loss, cost, or expense incurred as a result of any payment of a Loan on a date other than the last day of the Interest Period for such Loan including, but not limited to, acceleration of the Loans by Bank pursuant to Section 7.02. The Bank shall provide to Borrower therewith a statement setting forth the basis for, and a calculation in reasonable detail of the additional amounts to be paid to the Bank hereunder. Determinations by Bank of the additional amounts required to compensate Bank in respect of any loss, cost, or expense incurred as a result of any payment of a Loan on a date other than the last day of the Interest Period for such Loan, shall be
conclusive, provided that such determinations are made on a reasonable basis.

16

          Section 2.18     Letter of Credit Subfacility.  

          (a)     Issuance of Letters of Credit. From the Closing Date until the Maturity Date, subject to the terms and conditions hereof and of the Letter of Credit Documents, if any, and on such other terms and conditions that Bank may reasonably require, Bank may issue such Letters of Credit as Borrower may from time to time request for the benefit of Borrower or its Subsidiaries as provided herein; provided that (i) the aggregate amount of Letter of Credit Obligations shall not exceed the Letter of Credit Sublimit at any time, and (ii) the aggregate principal amount of all Advances outstanding at such time plus the face amount of the requested Letter of Credit, together with all other issued and outstanding Letters of Credit, does not exceed, at any time, the Revolving Commitment. No Letter of Credit shall have an expiration date later than the earlier of (x) the Maturity Date, or (y)
one year after the date of issuance thereof; provided, however, that Borrower may request issuance or renewal of a Letter of Credit with a later expiration if, at the time of such issuance or renewal, Borrower deposits an amount equal to the face amount of such Letter of Credit with Bank as cash collateral for such Letter of Credit. Each Letter of Credit shall require that all draws thereon must be presented to Bank by the expiration date therefor, regardless of whether presented prior to such date to any other institution. Each Letter of Credit shall comply with the related Letter of Credit Documents. The issuance date of each Letter of Credit shall be a Business Day.

          (b)     Notice and Reports. The request for the issuance of a Letter of Credit shall be submitted by Borrower to Bank at least five (5) Business Days prior to the requested date of issuance (or such shorter period as may be agreed to by Bank) pursuant to a Notice of Request for Letter of Credit, accompanied by such applications and other related documents as may be required by Bank. If the Notice of Request for Letter of Credit, related application and the requested form of such Letter of Credit is acceptable to Bank, Bank will, upon fulfillment of the applicable conditions set forth herein, make such Letter of Credit available to Borrower.

          (c)     Reimbursement. In the event of any drawing under any Letter of Credit, Bank will promptly notify Borrower, and to the extent such drawing is not immediately reimbursed by Borrower, Borrower shall request, or be deemed to have requested, an Advance in the amount of such drawing within five (5) days of such date, the proceeds of which will be used to satisfy the related reimbursement obligations, in which case a Revolving Loan shall be immediately made to Borrower by Bank and the proceeds thereof shall be reimbursed directly to Bank for application to the respective Letter of Credit Obligations.   Such Revolving Loan to Borrower shall be payable on demand.  Borrower’s reimbursement obligations hereunder shall be absolute and unconditional under all circumstances irrespective of any rights of setoff, counterclaim or defense to payment Borrower may
claim or have against Bank or the beneficiary of the Letter of Credit drawn upon or any other Person, including without limitation any defense based on any failure of Borrower to receive consideration or the legality, validity, regularity or unenforceability of the Letter of Credit.

17

          (d)     Borrower Responsible for All Letters of Credit. Notwithstanding anything to the contrary set forth in this Agreement, a Letter of Credit issued hereunder may contain a statement to the effect that such Letter of Credit is issued for the account, or to secure obligations, of a Subsidiary of Borrower, and, notwithstanding such statement, Borrower shall be for such Letter of Credit. Such statement shall not affect Borrower’s reimbursement obligations hereunder with respect to such Letter of Credit.

          (e)     International Standby Practices. The Bank may issue Letters of Credit subject to Rules on International Standby Practices, as adopted as of the date of issue by the International Chamber of Commerce (the “ISP”), in which case the ISP may be incorporated therein and deemed in all respects to be a part thereof.

          (f)     Letter of Credit Obligations Absolute. The obligations of Borrower under this Agreement, any Letter of Credit Document and any other agreement or instrument relating to any Letter of Credit shall be unconditional and irrevocable, and shall be paid strictly in accordance with the terms of this Agreement, such Letter of Credit Document and such other agreement or instrument under all circumstances, including without limitation the following circumstances:

	
  
 
  	
  
        (i)     any   lack of validity or enforceability of this Agreement, any Letter of Credit   Document, any Letter of Credit or any other agreement or instrument relating   thereto (this Agreement and all of the other foregoing being, collectively,   the “L/C Related Documents”);
  
	
  
 
  	
  
 
  
	
  
 
  	
  
        (ii)     any   change in the time, manner or place of payment of, or in any other term of,   all or any of the obligations of Borrower in respect of any L/C Related   Document or any other amendment or waiver of or any consent to departure from   all or any of the L/C Related Documents;
  
	
   
  	
  
 
  
	
  
 
  	
  
        (iii)     the   existence of any claim, set-off, defense or other right that Borrower may   have at any time against any beneficiary or any transferee of a Letter of   Credit (or any Persons for whom any such beneficiary or any such transferee   may be acting), Bank or any other Person, whether in connection with the   transactions contemplated by the L/C Related Documents or any unrelated   transaction;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
        (iv)     any   statement or any other document presented under a Letter of Credit proving to   be forged, fraudulent, invalid or insufficient in any respect or any   statement therein being untrue or inaccurate in any respect;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
        (v)     payment   by Bank under a Letter of Credit against presentation of a draft or   certificate that does not strictly comply with the terms of such Letter of   Credit;
  
	
  
 
  	
  
 
  
	
   
  	
  
        (vi)     any   exchange, release or non-perfection of any Collateral, or any release or   amendment or waiver of or consent to departure from any Loan Document; or
  
	
  
 
  	
  
 
  
	
  
 
  	
  
        (vii)     any   other circumstance or happening whatsoever, whether or not similar to any of   the foregoing, including without limitation any other circumstance that might   otherwise constitute a defense available to, or a discharge of, Borrower or   any Guarantor.
  

18

          Section 2.19     Conflict with Letter of Credit Documents.  In the event of any conflict between this Agreement and any Letter of Credit Document (including any letter of credit application), this Agreement shall control.

          Section 2.20     Cash Management.  Borrower shall (a) establish and maintain cash management services (including, without limitation, the Lockbox Account) of a type and on satisfactory terms, with Bank, and shall request in writing and otherwise take such reasonable steps to ensure that all Account Debtors of Borrower and each of its Domestic Subsidiaries forward payment of the amounts owed by them directly to such Lockbox Account, and (b) deposit or cause to be deposited, (i) promptly, and in any event no later than the first Business Day after the date of receipt thereof, all Collections received by Borrower or any Domestic Subsidiary, and (ii) all proceeds to be paid by, or otherwise transferred by, any Foreign Subsidiary to Borrower, into an account designated by Bank, subject to a satisfactory agreement by and among Borrower, Bank, and Borrower’s
Subsidiaries, providing that, if such account is held by an institution other than Bank, (A) all items of payment deposited in the Lockbox Account and proceeds thereof are held as agent or bailee-in-possession for Bank, (B) the Bank shall only have rights of setoff or recoupment for payment of its service fees and other charges directly related to the administration of such Lockbox Account, and for returned checks or other items of payment, and (C) upon notice from Bank following an Event of Default hereunder, it immediately will forward by daily sweep all amounts in the applicable Lockbox Account to a designated account.   The Lockbox Accounts (if more than one) shall be cash collateral accounts, securing the Obligations, in which Bank is granted a Lien and security interest hereunder.

ARTICLE III 
 CONDITIONS PRECEDENT

          Section 3.01     Condition Precedent.  This Agreement shall become effective as of the Closing Date, upon the satisfaction at or prior to the Closing Date of the following conditions:

          (a)     Loan Documents. The delivery of the following documents, agreements and instruments to Bank, each in form and substance satisfactory to Bank and its counsel:

	
  
 
  	
  
         (i)     this   Agreement together with the Schedules and Exhibits hereto duly completed by   Borrower;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
         (ii)    the   Note;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
         (iii)   a   document in which the Guarantors reaffirm the Guaranty;
  
	
   
  	
  
 
  
	
  
 
  	
  
         (iv)   the   Security Agreement;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
         (v)    such   UCC-1 or UCC-3 financing statements as Bank shall require, together with an   letter authorizing filing of the same, if required;
  

19

	
  
 
  	
  
         (vi)   the   reaffirmation containing the reaffirmation by the Borrower and of each   Subsidiary of the Borrower that is a party thereto of the Intercompany   Subordination Agreement, the Letter of Credit Documents, the Pledge   Agreement, the Tax Indemnity Agreement, the Lockbox Account Agreement, any   Hedge Agreement entered into by and between Borrower and Bank, and all other   agreements, instruments or documents now existing between the parties (the “Reaffirmation   of Original Loan Documents”);
  
	
  
 
  	
  
 
  
	
   
  	
  
         (vii)  all   other documents and instruments executed and delivered by third parties with   respect to the Collateral as Bank shall have requested;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
         (viii) insurance   certificates and related endorsements in favor of Bank, together with   evidence that the related insurance policies are in full force and effect and   meet the requirements of Section 5.05;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
         (ix)   a   loan certificate executed by an authorized signatory of Borrower and each   Guarantor, including a certificate of incumbency with respect to each officer   authorized to execute Loan Documents on behalf of such Person, together with   (A) a copy of such Person’s Organizational Documents, certified as true and   correct by the Secretary of State of the State of formation or organization   of such Person, (B) certificates from the Secretaries of State of those   states in which such Person is organized or formed, as the case may be,   certifying its good standing as a corporation in such states, in each case,   dated within thirty (30) days of the Closing Date, and (C) a copy of such   Person’s bylaws, operating or partnership agreement, in each case, certified   by the secretary or assistant secretary of such Person to be true and   correct; and
  
	
   
  	
  
 
  
	
  
 
  	
  
         (x)    
resolutions passed by the board of directors or written consents authorizing
Borrower’s and Guarantors’ execution and delivery of, and the
performance of the obligations under, this Agreement and the other Loan
Documents to which it is a party;
 

          (b)     Access Agreements. Borrower shall have obtained and delivered Access Agreements to Bank with respect to Borrower’s facilities in Lake Mary, Florida and Kennett Square, Pennsylvania.

          (c)     Due Diligence. Bank shall have completed its due diligence (including, without limitation, all appraisals, reviews and audits of Borrower’s business, assets and financial condition, material contracts, and lease agreements) and the results of the same shall be satisfactory to Bank;

          (d)     Financial Statements. Bank shall have received all of Borrower’s financial statements as filed with the Securities and Exchange Commission on Forms 10-K and 10-Q as Bank shall have requested (including, without limitation, Borrower’s reporting on Form 10-K of its financial results for the year ended December 31, 2005), in each case in form and substance satisfactory to Bank;

          (e)     Legal Opinions. Bank shall have received a favorable written legal opinions of counsel to Borrower, Guarantor and Holdco in form and substance satisfactory to Bank, including, without limitation, opinions of foreign counsel as may be required by Bank in connection with the pledge of the equity interests of Holdco;

20

          (f)     Payment of Fees. Borrower shall have paid all fees and expenses of Bank in connection with this Agreement;

           (g)     No Material Adverse Effect. No event or circumstance shall have occurred or exist that would have a Material Adverse Effect on Borrower, Guarantor, or any Subsidiary;

          (h)     Approvals and Consents. Borrower shall have obtained all applicable approvals and consents from governmental authorities required to consummate the transaction contemplated by this Agreement and the operation of its business, and of so requested, shall have provided Bank with a true and correct copy of such approvals and consents; and

          (i)     Other Documents. Bank shall have received such other approvals, opinions or other documents as Bank may reasonably request and each shall be in form and substance satisfactory to Bank.

          Bank hereby acknowledges that the conditions referenced in Sections 3.01(b), (c), (d), (g), and (h) have been satisfied, and no Advance beyond the $5,000,000 allowed under the Loan Agreement dated September 17, 2003, as amended, shall be allowed until the other conditions in this Section 3.01 have been satisfied.

          Section 3.02     Conditions to All Extensions of Credit.  The obligation of Bank to issue Letters of Credit, make other extensions of credit hereunder, or otherwise convert any portion of the Loan hereunder shall be subject to each of the following conditions:

          (a)     Representations and Warranties. The representations and warranties contained in this Agreement and the other Loan Documents shall be true and correct in all material respects on and as of the date of such extension of credit, as though made on and as of such date (except to the extent that such representations and warranties relate solely to an earlier date);

          (b)     No Default. No default or Event of Default shall have occurred and be continuing on the date of such extension of credit, nor shall either result from the making thereof;

          (c)     No Injunction. No injunction, writ, restraining order, or other order of any nature prohibiting, directly or indirectly, the extending of such credit shall have been issued and remain in force by any governmental authority against Borrower, Bank, or any of their Subsidiaries; and

          (d)     No Material Adverse Effect. The occurrence of any event or circumstance having a Material Adverse Effect.

ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES

          Borrower represents and warrants to Bank that:

21

          Section 4.01     Incorporation, Good Standing and Due Qualification.  Borrower and each Guarantor are corporations, limited liability companies, or partnerships duly incorporated or formed, as the case may be, validly existing, and in good standing under the laws of the State of their incorporation or formation, are duly qualified and in good standing as a foreign corporation authorized to do business in every jurisdiction where the failure to so qualify would have a Material Adverse Effect, and have the requisite corporate power and authority to own their respective properties and to operate their respective businesses as now conducted.

          Section 4.02     Corporate Power and Authority.  The execution, delivery and performance by Borrower of the Loan Documents has been duly authorized by all necessary corporate action and does not and will not (a) require any consent or approval of the stockholders, members, partners or other equity holders of Borrower, (b) contravene Borrower’s Organizational Documents, (c) violate any provision of any law, rule, regulation (including, without limitation, Regulations U and X of the Board of Governors of the Federal Reserve System), order, writ, judgment, injunction, decree, determination, or award presently in effect and applicable to Borrower or any Guarantor, (d) result in a breach of or constitute a default under any indenture or loan or credit agreement or any other agreement, lease, or instrument to which Borrower or any Guarantor is a party or by which
their respective properties may be bound or affected, (e) result in, or require, the creation or imposition of any Lien, upon or with respect to any of the properties now owned or hereafter acquired by Borrower, and (f) cause Borrower or any Guarantor to be in default under any such law, rule, regulation, order, writ, judgment, injunction, decree, determination, or award or any such indenture, agreement, lease, or instrument.

          Section 4.03     Legally Enforceable Agreement.  This Agreement is, and each of the other Loan Documents when delivered under this Agreement will be, legal, valid, and binding obligations of Borrower and each Guarantor, as the case may be, enforceable against such Person in accordance with their respective terms, except to the extent that such enforcement may be limited by applicable bankruptcy, insolvency, and other similar laws affecting creditors’ rights generally and the availability of equitable remedies.

          Section 4.04     Consents.  No consent, approval, authorization or order of, or filing, registration or qualification with, any court or Governmental Authority or third party in respect of Borrower or any Guarantor is required in connection with the execution, delivery or performance of this Agreement or any of the other Loan Documents, except (a) such filings as are necessary or desirable to perfect the security interests of the Bank under the Security Agreement and (b) such consents, approvals and authorizations as have been obtained.

          Section 4.05     Financial Statements.  The consolidated balance sheet of Borrower as at December 31, 2005, and the related statements of income and retained earnings of Borrower for the fiscal year then ended, reported on by Grant Thornton LLP and set forth in Borrower’s annual report for the year ended December 31, 2005, as filed with the Securities and Exchange Commission on Form 10-K, a copy of which has been delivered to the Bank, fairly represents, in conformity with GAAP, the consolidated position of Borrower and its Subsidiaries at such date and their consolidated results of operations and cash flows for such fiscal year.  Since the date of such financial statements,  there has been no occurrence or event that would have a Material Adverse Effect. There are no liabilities of Borrower, fixed or contingent, which are material but are not
reflected in the financial statements or in the notes thereto, other than liabilities arising in the ordinary course of business since December 31, 2005. 

22

          Section 4.06     Labor Disputes and Acts of God.  Neither the business nor the properties of Borrower are affected by any fire, explosion, accident, strike, lockout or other labor dispute, storm, hail, embargo, act of God, or other casualty (whether or not covered by insurance) which could have a Material Adverse Effect.

          Section
4.07     Litigation.  Except as
disclosed on Schedule 4.07 or in the Borrower’s Form 10-K dated June
29, 2006, there is no pending or to the knowledge of any officer of Borrower
threatened action or proceeding against or affecting Borrower before any court,
governmental agency, or arbitrator, in which there is a reasonable probability
of an adverse result which could, in any one case or in the aggregate, have a
Material Adverse Effect.

          Section
4.08     No Defaults on Outstanding Judgments or
Orders.  Except as described in the Borrower’s Form 10-K
dated June 29, 2006, Borrower has satisfied all judgments, and Borrower is
not in default with respect to any judgment, writ, injunction, decree, rule, or
regulation of any court, arbitrator, or federal, state, municipal, or other
governmental authority, commission, board, bureau, agency, or instrumentality,
domestic or foreign which could have a Material Adverse Effect.

          Section 4.09     Ownership and Liens.  Borrower has title to, or valid leasehold interests in, all of the properties and assets, real and personal, including the properties and assets and leasehold interest reflected in the financial statements referred to in Section 4.05 (other than any properties or assets disposed of following the dates of such financial statements), and none of the properties and assets owned by Borrower and none of its leasehold interests is subject to any Lien, except for Permitted Liens.

          Section 4.10     Subsidiaries.  As of the date hereof: 

          (a)     Borrower’s Subsidiaries are set forth on Schedule 4.10; 

          (b)     Borrower’s only Domestic Subsidiaries are Faro Delaware, Inc., a Delaware corporation, and Faro Laser Trackers, LLC, a Delaware limited liability company of which Borrower and Faro Delaware, Inc. are members; and

          (c)     Borrower is the sole owner of every Domestic Subsidiary, except Faro Laser Trackers, LLC, which is owned by Borrower and Faro Delaware, Inc.  Borrower and Faro Delaware, Inc. are the sole owners of Holdco, a Foreign Subsidiary.  Borrower and Holdco are the sole owners of every other Foreign Subsidiary.

          Section 4.11     ERISA.  Borrower is in compliance in all material respects with all applicable provisions of ERISA. Neither a Reportable Event nor a Prohibited Transaction has occurred and is continuing with respect to any Plan; no notice of intent to terminate a Plan has been filed, nor has any Plan been terminated; no circumstances exist which constitute grounds entitling the PBGC to institute proceedings to terminate, or appoint a trustee to administer, a Plan, nor has the PBGC instituted any such proceedings; Borrower has not completely or partially withdrawn from a Multiemployer Plan; Borrower has met its minimum funding requirements under ERISA with respect to all of their Plans, and the present value of all vested benefits under each Plan does not exceed the fair market value of all Plan assets allocable to such benefits, as determined on the most recent
valuation date of the Plan and in accordance with the provisions of ERISA; and Borrower has not incurred any liability to the PBGC under ERISA.

23

          Section 4.12     Operation of Business.  Borrower possesses all material licenses, permits, franchises, patents, copyrights, trademarks, and trade names, or rights thereto, to conduct its business substantially as now conducted and as presently proposed to be conducted, and Borrower is not in violation of any valid rights of others with respect to any of the foregoing.

          Section 4.13     Taxes.  Borrower and each of its Subsidiaries has (a) filed, or caused to be filed, all material tax returns (federal, state, local and foreign) required to be filed and paid all amounts of taxes shown thereon to be due (including interest and penalties), and (b) paid all other taxes, fees, assessments and other governmental charges (including mortgage recording taxes, documentary stamp taxes and intangibles taxes) owing (or necessary to preserve any liens in favor of the Bank) by it, except for such taxes (i) that are not yet delinquent, or (ii) that are the subject of a protest being diligently pursued by Borrower or such Subsidiary.

          Section 4.14     Environmental.  Borrower has duly complied with, and its business, operations, assets, equipment, property, leaseholds, or other facilities are in compliance with, the provisions of all applicable federal, state, and local environmental, health, and safety laws, codes and ordinances, and all rules and regulations promulgated thereunder.  Borrower has been issued and will maintain all required federal, state, and local permits, licenses, certificates, and approvals relating to environmental, health, or safety matters.

          Section 4.15     Indebtedness. Borrower is not directly or contingently obligated under any credit agreement, indenture, purchase agreement, Capital Lease, or other agreement involving the extension of credit from any third party other than (a) Bank, (b) as described in the financial statements described in Section 4.05, and (c) Permitted Indebtedness.

          Section 4.16     Investments in Subsidiaries; Intercompany Loans and Advances.  As of the Closing Date, Borrower’s investments in, and intercompany loans and advances made to, each of its Subsidiaries (including Holdco) are as set forth on Schedule 4.16.

          Section 4.17     Solvency.  Borrower, each of its Subsidiaries and each of the Guarantors are, and, after consummation of this Agreement and after giving effect to all Indebtedness incurred hereunder, will be, Solvent. No transfer of property is being made by Borrower and no obligation is being incurred by Borrower or any Guarantor in connection with the transactions contemplated by this Agreement or the other Loan Documents with the intent to hinder, delay, or defraud either present or future creditors of Borrower or any Guarantor.

          Section 4.18     Other Agreements.  Borrower is not a party to any indenture, loan, or credit agreement, or to any lease or other agreement or instrument, or subject to any charter or corporate restriction which could have a Material Adverse Effect. Borrower is not in default in any material respect in the performance, observance, or fulfillment of any of the obligations, covenants, or conditions contained in any agreement or instrument material to its business to which it is a party.

24

          Section 4.19     No Materially Misleading Facts.  No information, exhibit, or report furnished by Borrower to Bank in connection with the negotiation of this Agreement contains, when read in context or in connection with other reports and information furnished to Bank by Borrower, any material misstatement of fact or omitted to state a material fact or any fact necessary to make the statement contained therein not materially misleading.

ARTICLE V 
 AFFIRMATIVE COVENANTS

          So long as the Obligations shall remain outstanding, Borrower shall:

          Section 5.01     Maintain Existence.  Preserve and maintain its corporate existence and good standing in the jurisdiction of its incorporation or formation, and qualify and remain qualified as a foreign corporation in each other jurisdiction where the failure to do so would have a Material Adverse Effect.

          Section 5.02     Maintain Books and Records.  Keep adequate books and records of accounts, in which complete entries will be made in accordance with GAAP consistently applied, reflecting all financial transactions of Borrower.

          Section 5.03     Maintain Properties.  Maintain, keep, and preserve all of its properties (tangible and intangible) necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and tear excepted.

          Section 5.04     Conduct of Business.  Continue to engage in an efficient and economical manner in a business of the same general type as now conducted by it on the date of this Agreement.

          Section 5.05     Maintain Insurance.  

          (a)     General Liability, Business Interruption, and other Insurance Coverage. With respect to the operation of Borrower’s business and insurance for the Collateral, Borrower shall, at its expense, maintain insurance in such amounts and covering such risks as is usually carried by companies engaged in similar businesses in which Borrower operates, including, without limitation, comprehensive general liability insurance, worker’s compensation, and business interruption insurance.

           (b)     Insurance Companies. Maintain such other insurance required by Bank under this Agreement in form, and with insurers recognized as satisfactory to Bank, and all such policies shall be in such amounts as may be reasonably satisfactory to Bank and shall, by an endorsement or independent instrument furnished to Bank provide that the insurance companies will give Bank at least thirty (30) days prior written notice (ten (10) days, in the case of non­payment of premium) before any such policy or policies of insurance shall be altered or canceled. All policies of insurance shall contain an endorsement in form and substance satisfactory to Bank, showing Bank as an additional insured, or loss payee, as applicable. If any loss shall occur at any time after the occurrence and during the continuation of any Event of Default, Bank shall be entitled to the benefit of all
insurance proceeds payable to Borrower to the same extent as if such proceeds had been paid to Bank. Bank shall have the right, but not the obligation, to make premium payments, at Borrower’s expense, to prevent any cancellation of any policy of insurance maintained by Borrower.

25

          Section 5.06     Compliance With Laws.  To the extent that failure to comply would be material, comply in all material respects with all applicable laws, rules, regulations, and orders, such compliance to include, without limitation, paying before the same become delinquent all taxes, assessments, and governmental charges imposed upon it or upon its property except where contested in good faith and by proper proceedings if appropriate reserves are maintained with respect thereto.

          Section 5.07     Payment of Taxes and Indebtedness.  For itself, and cause each of its Subsidiaries to, (a) pay and discharge, before the same shall become delinquent, all taxes, assessments and governmental charges or levies imposed, (b) timely file all information returns required by federal, state or local taxing authorities, (c) pay any and all of its Indebtedness when and as it becomes due, other than amounts duly disputed in good faith, and (d) promptly perform its obligations under all material contracts.

          Section 5.08     Right of Inspection.  At any reasonable time and from time to time, subject to the confidentiality provisions of Section 8.18, permit Bank or any agent or representative thereof to examine and make copies of and abstracts from the records and books of account of, and visit the properties of. Borrower and to discuss the affairs, finances, and accounts of Borrower with any of its respective officers and directors and Borrower’s independent accountants.

          Section 5.09     Further Assurances.  Promptly, at its expense, execute and deliver to Bank, or cause to be executed and delivered to Bank, all such other and further documents, agreements, and instruments in compliance with or accomplishment of the covenants and agreements of the Loan Documents, including this Agreement, or to correct any omissions in the Loan Documents, or to obtain any consents which are necessary in connection with or in accomplishment of the covenants and agreements of Borrower under the Loan Documents, all as may be necessary or appropriate in connection therewith or as may be requested by Bank.

          Section 5.10     Use of Proceeds.  Use the proceeds of the Loans hereunder only as described in Section 2.14.

          Section 5.11     Environment.  Be and remain in compliance with the provisions of all federal, state, and local environmental, health, and safety laws, codes and ordinances, and all rules and regulations issued thereunder; notify Bank immediately of any notice of a hazardous discharge or environmental complaint received from any governmental agency or any other party; notify Bank immediately of any hazardous discharge from or affecting its premises; immediately contain and remove the same, in compliance with all applicable laws; promptly pay any fine or penalty assessed in connection therewith; permit Bank to inspect the premises, to conduct tests thereon, and to inspect all books, correspondence, and records pertaining thereto; and at Bank’s request, and at Borrower’s expense, provide a report of a qualified environmental engineer, satisfactory in
scope, form, and content to Bank, and such other and further assurances reasonably satisfactory to Bank that the condition has been corrected.

26

          Section 5.12     Reporting Requirements.  Furnish to Bank:

           (a)     Quarterly Financial Reports. As soon as available and in any event within forty-five (45) days after the end of each quarter (except the last) of each fiscal year of Borrower, Borrower’s Form 10-Q, as filed with the Securities and Exchange Commission, including consolidated balance sheets of Borrower as of the end of such quarter, consolidated statements of income and retained earnings of Borrower for the period commencing at the end of the previous fiscal year and ending with the end of such quarter, and consolidated statements of changes in financial position of Borrower for the portion of the fiscal year ended with the last day of such quarter;

          (b)     Annual Financial Report. As soon as available and in any event within one ninety (90) days after the end of each fiscal year of Borrower (it being assumed that Borrower’s
Form 10-K normally would be filed with the Securities and Exchange
Commission within seventy-five (75) days of the end of Borrower’s fiscal
year), Borrower’s Form 10-K, as filed with the Securities and Exchange
Commission, including consolidated balance sheets of Borrower as of the end of
such fiscal year and consolidated statements of income and retained earnings of
Borrower for such fiscal year and consolidated statements of changes in
financial position of Borrower for such fiscal year, all as reported on in
accordance with the rules and regulations of the Securities and Exchange
Commission and audited by Grant Thornton LLP or other independent public
accountants of nationally recognized standing;

          (c)     Other Filings.  Promptly upon their filing with the Securities and Exchange Commission, all reports and filings made by Borrower.

          (d)     Management Letters. Promptly upon receipt thereof, copies of any reports submitted to Borrower by independent certified public accountants in connection with examination of the financial statements of Borrower made by such accountants;

          (d)     Certificate of No Default. Within forty-five (45) days after the end of each of the quarters of each fiscal year of Borrower, a certificate of the chief financial officer of Borrower (i) certifying that to the best of such officer’s knowledge no Default or Event of Default has occurred and is continuing or, if a Default or Event of Default has occurred and is continuing, a statement as to the nature thereof and the action which is proposed to be taken with respect thereto and (ii) with computations demonstrating compliance with the covenants contained in Section 5.13;

          (e)     Collateral Reporting.  Upon request of Bank, such reports with respect to the Collateral as Bank reasonably shall request, each in form and substance satisfactory to Bank.

          (f)     Notice of Litigation. Promptly after the commencement thereof, notice of all actions, suits, and proceedings before any court or governmental department, commission, board, bureau, agency, or instrumentality, domestic or foreign, affecting Borrower which, if determined adversely to Borrower, could have a Material Adverse Effect;

          (g)     Notice of Defaults and Events of Default. As soon as possible and in any event within ten (10) days after the occurrence of each Default or Event of Default, a written notice setting forth the details of such Default or Event of Default and the action which is proposed to be taken by Borrower with respect thereto;

27

          (h)     ERISA Reports. As soon as possible, and in any event within thirty (30) days after Borrower knows or has reason to know that any circumstances exist that constitute grounds entitling the PBGC to institute proceedings to terminate a Plan subject to ERISA with respect to Borrower, Borrower will deliver to Bank a certificate of the chief financial officer of Borrower setting forth all relevant details and the action which Borrower proposes to take with respect thereto;

           (i)     Notices, Consents and Material Financial Reports to Other Creditors. Promptly after the furnishing thereof, copies of any notices, consents or material financial reports furnished to any other party pursuant to the terms of any indenture (in the case of the issuance of notes), loan, credit, or similar agreement (in the case of borrowed money), and not otherwise required to be furnished to Bank pursuant to any other clause of this Section;

          (j)     General Information. Such other information respecting the condition or operations, financial or otherwise, of Borrower as Bank may from time to time reasonably request.

          Section 5.13     Financial Covenants.  Comply with all of the following financial covenants, each of which shall be calculated in accordance with GAAP consistently applied:

          (a)     Minimum Current Ratio. Borrower shall maintain a Current Ratio of not less than 2.5 to 1.0, measured as of the end of each of Borrower’s fiscal quarters.

          (b)     Minimum Consolidated EBITDA. Borrower shall maintain a Consolidated EBITDA, measured as of the end of each of Borrower’s fiscal quarters for the rolling period of four fiscal quarters just ended, of not less than (i) $8,000,000 for all periods through December 31, 2006, and (ii) $9,000,000 thereafter.

          (c)     Maximum Senior Funded Debt to EBITDA. Borrower shall maintain a ratio of Senior Funded Debt to EBITDA of not more than 2.25 to 1.0, tested at the end of each of Borrower’s fiscal quarters; provided, however, that (i) Senior Funded Debt shall be measured as of the end of such fiscal quarter, and (ii) EBITDA shall be measured for the rolling period of four fiscal quarters ending with such fiscal quarter.

ARTICLE VI 
 NEGATIVE COVENANTS

          Borrower covenants and agrees that so long as any portion of the Obligations shall remain unpaid, Borrower shall not, and shall not permit its Subsidiaries to, without the prior written consent of Bank:

          Section 6.01     Liens.  Create, incur, assume, or suffer to exist, or permit any Subsidiary to create, incur, assume, or suffer to exist, any Lien, upon or with respect to any of its properties, now owned or hereafter acquired, except for Permitted Liens.

28

          Section 6.02     Indebtedness.  Create, incur, assume, or suffer to exist, or permit any Subsidiary to create, incur, assume, or suffer to exist, any Indebtedness, except for (a) Permitted Indebtedness and (b) refinancing, renewals of or extensions of Permitted Indebtedness, provided, that Borrower shall only be permitted to refinance, renew or extend such Permitted Indebtedness without Bank’s prior written consent if (i) the terms and conditions of such refinancings, renewals, or extensions do not, in Bank’s judgment, materially impair the prospects of repayment of the Obligations by Borrower or materially impair Borrower’s creditworthiness, (ii) such refinancings, renewals, or extensions do not result in an increase in the principal amount of, or interest rate with respect to, the Indebtedness so refinanced, renewed, or extended, (iii) such
refinancings, renewals, or extensions do not result in a shortening of the average weighted maturity of the Indebtedness so refinanced, renewed, or extended, nor are they on terms or conditions, that, taken as a whole, are materially more burdensome or restrictive to Borrower, and (iv) if the Indebtedness that is refinanced, renewed, or extended was subordinated in right of payment to the Obligations, then the terms and conditions of the refinancing, renewal, or extension Indebtedness must include subordination terms and conditions that are at least as favorable to Bank as those that were applicable to the refinanced, renewed, or extended Indebtedness.

          Section 6.03     Subsidiaries; Mergers; Reorganizations and Permitted Acquisitions of Domestic Subsidiaries.  (a) Form any Domestic Subsidiary after the Closing Date (unless such Domestic Subsidiary becomes a Guarantor hereunder, becomes a party to the Security Agreement and Borrower makes a pledge to the Bank of its equity interests in such Domestic Subsidiary); (b) wind up, liquidate or dissolve itself, reorganize, merge or consolidate with or into any Person; (c) make an Asset Sale, other than a Permitted Asset Sale; or (d) make any Acquisition, other than a Permitted Acquisition; provided that if the result of any such Permitted Acquisition is the creation or addition of a Domestic Subsidiary, such Domestic Subsidiary shall become a Guarantor hereunder, become a party to the Security Agreement and Borrower shall make a pledge to the Bank of its equity
interests in such Domestic Subsidiary.

          Section 6.04     Sale and Leaseback.  Sell, transfer, or otherwise dispose of any real or personal property to any Person and thereafter directly or indirectly lease back the same or similar property without the prior written consent of Bank.

          Section 6.05     Dividends.  Except with respect to Dividends payable to Borrower, declare or pay any Dividends; or purchase, redeem, retire, or otherwise acquire for value any of its capital stock now or hereafter outstanding, or allocate or otherwise set apart any sum for the payment of any Dividends, or for the purchase, redemption, or retirement of any shares of its capital stock. Notwithstanding the foregoing, Borrower is permitted to make Dividends to its shareholders provided that Borrower has satisfied (and is projected to continue satisfying) the financial covenants set forth in Section 5.13, and no other Default or Event of Default has occurred or is continuing, or would result from the making thereof.

          Section 6.06     No Impairment of Intercompany Payments.  Directly or indirectly enter into or become bound by any agreement, instrument, indenture or other obligation (other than this Agreement and the other Loan Documents) that could directly or indirectly restrict, prohibit or require the consent of any Person with respect to the payment of Dividends or distributions or the making or repayment of intercompany loans by a Subsidiary of Borrower, to Borrower.

29

          Section 6.07     Asset Sales.  Sell, lease, assign, transfer, or otherwise dispose of any of its now owned or hereafter acquired assets (including, without limitation, shares of stock and indebtedness of Subsidiaries, receivables, and leasehold interests) in any one transaction or a series of transactions, except, that provided no Default or Event of Default has occurred hereunder, Borrower may sell or dispose of (a) inventory in the ordinary course of business, (b) assets no longer used or useful in the conduct of its business, and (c) Permitted Asset Sales.

          Section 6.08     Investments and Intercompany Loans and Advances.  Except (a) as otherwise expressly permitted in this Agreement, and (b) as required by applicable law (including the law of any foreign jurisdiction having direct authority over Holdco or any other direct or indirect Foreign Subsidiary), make, or permit to exist, any investment in, or make, accrue or permit to exist, loans or advances of money to, any Person, through the direct or indirect lending of money, holding of securities or otherwise, except that Borrower and each of its Subsidiaries may (x) maintain their respective investments in Subsidiaries as of the Closing Date as set forth on Schedule 4.16; and (y) make all other investments (including those required by applicable foreign law), intercompany loans and advances, subject to the terms and conditions set forth in the Intercompany
Subordination Agreement.

          Section 6.09     Guarantees.  Assume, guaranty, endorse, or otherwise be or become directly or contingently responsible or liable (including, but not limited to, an agreement to purchase any obligation, stock, assets, goods, or services, or to supply or advance any funds, assets, goods, or services, or an agreement to maintain or cause such Person to maintain a minimum working capital or net worth, or otherwise to assure the creditors of any Person against loss) for obligations of any Person, except guaranties by endorsement of negotiable instruments for deposits or collection or similar transactions in the ordinary course of business and guarantees of Permitted Indebtedness.

          Section 6.10     Transactions With Affiliates.  To the extent not restricted elsewhere in this Article VI, (a) enter into any transaction, including, without limitation, the purchase, sale, or exchange of property or the rendering of any service, with any Affiliate, except in the ordinary course of and pursuant to the reasonable requirements of Borrower’s business and upon fair and reasonable terms no less favorable to Borrower than would obtain in a comparable arm’s-length transaction with a Person that is not an Affiliate, or (b) enter into any lending or borrowing transaction with any employees of Borrower or any Subsidiary, except loans to its respective employees in the ordinary course of business consistent with past practices for travel and entertainment expenses, relocation costs and similar purposes up to a maximum of $250,000 in the
aggregate at any one time outstanding.

          Section 6.11     Financial Covenants.  Breach or fail to comply with any of the financial covenants set forth in Section 5.13.

ARTICLE VII 
 EVENTS OF DEFAULT AND REMEDIES

          Section 7.01     Events of Default.  The following shall constitute Events of Default hereunder:

30

          (a)     Borrower should fail to (i) pay the principal when due, and (ii) pay any interest or fee, within five (5) days of the date that such interest or fee is due and payable;

          (b)     Any representation or warranty made or deemed made by Borrower in this Agreement or which is contained in any certificate, document, opinion, or financial or other statement furnished at any time under or in connection with any Loan Document shall prove to have been incorrect, incomplete, or misleading in any material respect on or as of the date made or deemed made;

          (c)     Borrower shall fail to perform or observe any term, covenant, or agreement contained in Articles V or VI hereof;

          (d)     Borrower shall fail to perform or observe any other material agreement or covenant set forth in this Agreement, or in any other Loan Document, and shall not cure such failure within any applicable cure period;

          (e)     Borrower shall, with respect to any other Indebtedness not otherwise provided for in this Section 7.01 in excess of $1,000,000 in the aggregate, (i) fail to pay any interest or premium thereon when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) subject to applicable notice and cure periods, or (ii) fail to perform or observe any term, covenant, or condition on its part to be performed or observed under any agreement or instrument relating to any such debt, if the effect of such failure to perform or observe is to accelerate, or to permit the acceleration of, after the giving of notice or passage of time, or both, the maturity of such indebtedness, whether or not such failure to perform or observe shall be waived by the holder of such Indebtedness; or any such debt shall be declared to be due and payable, or required to be
prepaid (other than by a regularly scheduled required prepayment), prior to the stated maturity thereof, provided that the foregoing should not be continued to permit the existence of any Indebtedness in violation of Section 6.02;

          (f)     Borrower (i) shall generally not pay, or shall be unable to pay, or shall admit in writing its inability to pay its debts as such debts become due, or (ii) shall make an assignment for the benefit of creditors, or petition or apply to any tribunal for the appointment of a custodian, receiver, or trustee for it or a substantial part of its assets, or (iii) shall commence any proceeding under any insolvency proceeding, or (iv) shall have had any such insolvency proceeding commenced against it in which an order for relief is entered or an adjudication or appointment is made, and which remains undismissed for a period of thirty (30) days or more, or (v) shall take any corporate action indicating its consent to, approval of, or acquiescence in any such petition, application, proceeding, or order for relief or the appointment of a custodian, receiver, or trustee for all or any
substantial part of its properties, or (vi) shall suffer any such custodianship, receivership, or trusteeship to continue undischarged for a period of thirty (30) days or more;

           (g)     One or more judgments, decrees, or orders for the payment of money in excess of ONE HUNDRED THOUSAND DOLLARS ($100,000.00) in the aggregate shall be rendered against Borrower, and such judgments, decrees, or orders shall continue unsatisfied and in effect for a period of thirty (30) consecutive days without being vacated, discharged, satisfied, or stayed or bonded pending appeal;

31

          (h)     Any of the following events shall occur or exist with respect to Borrower under ERISA which would reasonably be expected to result in liability to Borrower in excess of ONE HUNDRED THOUSAND DOLLARS ($100,000.00) (i) any Reportable Event shall occur, (ii) complete or partial withdrawal from any Multi-Employer Plan shall take place, (iii) any Prohibited Transaction shall occur, (iv) a notice of intent to terminate a Plan shall be filed, or (v) a Plan shall be terminated;

          (i)     A Change of Control shall have occurred;

          (j)     The failure of any Guaranty, or the failure of any Guarantor to perform its respective obligations under any Guaranty; or

          (k)     Any security interest or mortgage granted to Bank pursuant to the Security Agreement ceases to be perfected or have first priority.

          Section 7.02     Remedies.

          (a)     Upon the occurrence and during the continuance of any Event of Default, the Bank may cease making any additional Advances;

          (b)     In the case of any Event of Default specified in Sections 7.01 (a), (b), (f), (i), (j) or (k), or Section 5.12(f), without any notice to Borrower, the Note, all interest thereon, and all other amounts payable under this Agreement shall become and be forthwith due and payable, without presentment, demand, protest, or notice of any kind, all of which are hereby expressly waived by Borrower;

          (c)     Except for an Event of Default resulting from Borrower’s failure to comply with Section 5.12(f)), in the case of any Event of Default specified in Sections 7.01(c) or (e), Bank may, by notice to Borrower, declare the Note, all interest thereon, and all other amounts payable under this Agreement to be forthwith due and payable, whereupon the Note, all such interest, and all such amounts shall become and be forthwith due and payable, without presentment, demand, protest, or further notice of any kind, all of which are hereby expressly waived by Borrower;

          (d)     In the case of any Event of Default not specified in clauses (b) and (c) above, if Borrower shall fail to cure such default within thirty (30) days after the date on which the Bank provides written notice to Borrower (or, in the case of an Event of Default with respect to which Borrower is obligated to deliver notice to Bank, the date on which Borrower provides notice to Bank of such an Event of Default), the Bank, at its option, without further notice, may declare the Note, all interest thereon, and all other amounts payable under this Agreement to be forthwith due and payable, whereupon the Note, all such interest, and all such amounts shall become and be forthwith due and payable, without presentment, demand, protest, or further notice of any kind, all of which are hereby expressly waived by Borrower. Notwithstanding the foregoing, in the event that Borrower has
commenced and is diligently proceeding to cure such Event of Default, Borrower shall have such additional time (not in excess of thirty (30) days) to effectuate such cure.

32

           (e)     Upon the occurrence and during the continuance an Event of Default, after applicable notice and applicable cure periods, if any, Bank is hereby authorized at any time and from time to time, without further notice to Borrower (any such notice being expressly waived by Borrower), to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by Bank to or for the credit or the account of Borrower against any and all of the obligations of Borrower now or hereafter existing under this Agreement or the Notes or any other Loan Document, irrespective of whether or not Bank shall have made any demand under this Agreement or the Notes or such other Loan Document and although such obligations may be unmatured. Bank agrees promptly to notify Borrower after any such setoff and
application, provided that the failure to give such notice shall not affect the validity of such setoff and application. The rights of Bank under this Section are in addition to other rights and remedies (including, without limitation, other rights of setoff) which Bank may have;

          (f)     Upon the occurrence and during the continuance an Event of Default, Bank may exercise all of the post-default rights granted to it under the Loan Documents or under applicable law. The rights and remedies of Bank hereunder shall be cumulative, and not exclusive. The exercise of one or more such remedies shall not preclude or prevent Bank from, at the same time, or at any other time, resorting to or exercising the same or other rights, powers, privileges or remedies herein granted to it or to which it might otherwise legally resort.

          Section 7.03     Cash Collateralization of Letters of Credit.  Bank may, irrespective of whether it is taking any of the actions described in this Section, under the Security Agreement or otherwise, make demand upon Borrower to, and forthwith upon such demand Borrower will, pay to Bank in same-day funds, for deposit in such account as Bank shall specify (the “L/C Cash Collateral Account”), an amount equal to 105% of the Letter of Credit Obligations then outstanding. The L/C Cash Collateral Account shall be in the name and under the sole dominion and control of Bank. Bank shall have no obligation to invest any amounts on deposit in the L/C Cash Collateral Account. Borrower grants to Bank, a lien on and security interest in the L/C Cash Collateral Account and all amounts on deposit therein as collateral security for the performance of its
obligations under this Agreement and the other Loan Documents. Bank shall have all rights and remedies available to it under applicable law with respect to the L/C Cash Collateral Account and all amounts on deposit therein.

          Section 7.04     Grant of Royalty-Free License Following Event of Default.  To the extent that following the occurrence of an Event of Default the Bank or anyone claiming through the Bank has foreclosed upon or is liquidating any of the Collateral, Borrower hereby grants the Bank or such other person a royalty-free license to use any or all of Borrower’s intellectual property to the extent necessary to hold and sell such Collateral in a reasonable and businesslike manner. 

ARTICLE VIII 
 MISCELLANEOUS

          Section 8.01     Effectiveness.  This Agreement shall be binding and deemed effective when executed by Borrower and Bank and the conditions set forth in Section 3.01 have been fully satisfied or waived by Bank in writing.

33

          Section 8.02     Amendments and Waivers.  No amendment, modification, termination, or waiver of any provision of any Loan Document to which Borrower is a party, nor consent to any departure by Borrower from any Loan Document to which it is a party, shall in any event be effective unless the same shall be in writing and signed by Bank, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.

          Section 8.03     Notices.  All notices and other communications under this Agreement shall be in writing and shall be deemed to have been given upon the earlier of receipt or three (3) Business Days from the date of deposit in the mail, designated as certified mail, return receipt requested, post-prepaid, or one (1) Business Day after being entrusted to a reputable commercial overnight delivery service, or when delivered to the telegraph office or sent out by telex or telecopy addressed to the party to which such notice is directed at its address determined as provided in this Section 8.03 during the recipient’s normal business hours, except that notices to Bank pursuant to Article II shall not be effective until received by Bank. All notices and other communications under this Agreement (other than with respect to routine conversions/continuations and
repayments) shall be given to the parties hereto at the following addresses:

	
  
 
  	
  
If to   Borrower:
  	
  
FARO   TECHNOLOGIES, INC.
  
	
  
 
  	
  
 
  	
  
125   Technology Park
  
	
  
 
  	
  
 
  	
  
Lake Mary,   Florida 32746
  
	
  
 
  	
  
 
  	
  
Attention:   Simon Raab
  
	
  
 
  	
  
 
  	
  
Telecopier:   (407) 333-4181
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
with a copy   to:
  	
  
FOLEY &   LARDNER LLP
  
	
  
 
  	
  
 
  	
  
100 North   Tampa Street
  
	
  
 
  	
  
 
  	
  
Suite 2700
  
	
  
 
  	
  
 
  	
  
Tampa,   Florida 33602
  
	
  
 
  	
  
 
  	
  
Attention:   Steven W. Vazquez, Esq.
  
	
  
 
  	
  
 
  	
  
Telecopier:   (813) 221-4210
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
If to Bank:
  	
  
SUNTRUST   BANK
  
	
   
  	
  
 
  	
  
200 South   Orange Avenue
  
	
  
 
  	
  
 
  	
  
Orlando,   Florida 32801
  
	
  
 
  	
  
 
  	
  
Attention:   Scott G. Balke
  
	
  
 
  	
  
 
  	
  
Telecopier:   (407) 237-6030
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
with a copy   to:
  	
  
HOLLAND   & KNIGHT LLP
  
	
  
 
  	
  
 
  	
  
200 South   Orange Avenue, Suite 2600
  
	
  
 
  	
  
 
  	
  
Orlando,   Florida 32801
  
	
   
  	
  
 
  	
  
Attention:  Leighton D. Yates, Jr.
  
	
  
 
  	
  
 
  	
  
Telecopier:   (407) 244-1126
  

34

          Any party hereto may change the address to which notices shall be directed under this Section 8.03 by giving ten (10) days’ written notice of such change to the other party.

          Section 8.04     No Waiver.  No failure or delay on the part of Bank in exercising any right, power, or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any such right, power, or remedy preclude any other or further exercise thereof or the exercise of any other right, power, or remedy hereunder. The rights and remedies provided herein are cumulative, and are not exclusive of any other rights, powers, privileges, or remedies, now or hereafter existing, at law or in equity or otherwise.

          Section 8.05     Successors and Assigns.  This Agreement shall bind and inure to the benefit of the respective successors and assigns of each of the parties. Borrower may not assign this Agreement or any rights or duties hereunder without Bank’s prior written consent and any prohibited assignment shall be void. No consent to assignment by Bank shall release Borrower from its Obligations. Bank may assign this Agreement and the other Loan Documents and its rights and duties hereunder and thereunder, in accordance with Section 8.09 hereof.

          Section 8.06     Costs, Expenses, and Taxes.  Borrower agrees to pay on demand all costs and expenses incurred by Bank in connection with the preparation, execution, delivery, filing, and administration of the Loan Documents and the Letters of Credit (including the Letter of Credit Fees), and of any amendment, modification, or supplement to the Loan Documents, including, without limitation, the fees and out-of-pocket expenses of counsel for Bank incurred in connection with advising Bank as to its rights and responsibilities hereunder. Borrower also agrees to pay all such costs and expenses, including court costs, incurred in connection with enforcement of the Loan Documents, or any amendment, modification, or supplement thereto, whether by negotiation, legal proceedings, or otherwise. Borrower shall also pay all audit, appraisal and valuation fees and
charges, whether Bank elects to perform such audits, appraisals and valuations itself or through the services of one or more third Persons. In addition, Borrower shall pay any and all documentary stamp and other taxes and fees payable or determined to be payable in connection with the execution, delivery, filing, and recording of any of the Loan Documents and the other documents to be delivered under any such Loan Documents, and agrees to hold Bank harmless from and against any and all liabilities with respect to or resulting from any delay in paying or omission to pay such taxes and fees. This provision shall survive termination of this Agreement.

          Section 8.07     Integration.  This Agreement and the Loan Documents contain the entire agreement between the parties relating to the subject matter hereof and supersede all oral statements and prior writings with respect thereto.

          Section 8.08     Indemnity.  Borrower agrees to indemnify and hold harmless Bank and each of its affiliates, employees, representatives, officers, directors, agents and attorneys (any of the foregoing shall be an ‘‘Indemnitee”) from and against any and all claims, liabilities, losses, damages, actions, investigations, proceedings, attorneys’ fees and expenses (as such fees and expenses are incurred and irrespective of whether suit is brought) and demands by any party, including the costs of investigating and defending such claims, actions, investigations or proceedings, and the costs of answering any discovery served in connection therewith, whether or not Borrower or the Person seeking indemnification is the prevailing party and whether or not the Person seeking indemnification is a party to any such action or proceeding (a) resulting
from any breach or alleged breach by Borrower of any representations or warranties made hereunder, or (b) arising out of (i) the Loans, issuance of Letters of Credit, or otherwise under this Agreement, including the use of the proceeds of the Loans hereunder in any fashion by Borrower or the performance of its obligations under the Loan Documents by Borrower, (ii) allegations of any participation by Bank in the affairs of Borrower, or allegations that Bank has any joint liability with Borrower for any reason, or (iii) any claims against Bank by any shareholder or other investor in or Bank to Borrower, by any brokers or finders or investment advisers or investment bankers retained by Borrower or by any other third party, for any reason whatsoever, or (c) in connection with taxes, fees, and other charges payable in connection with the Loans, or the execution, delivery, and enforcement of this Agreement, the other Loan Documents, and any subsequent amendments thereto or waivers of any of the provisions
thereof, unless the Person seeking indemnification hereunder is determined in such case to have acted or failed to act with gross negligence or willful misconduct by a non-appealable judicial order. This indemnity shall survive termination of this Agreement.

35

          Section 8.09     Assignments; Participations.

          (a)     Assignments. Bank may assign and delegate to one or more assignees (each an “Assignee”) all or any ratable portion of the Obligations and the other rights and obligations of Bank hereunder and under the other Loan Documents, provided, that, Borrower may continue to deal solely and directly with Bank in connection with the interest so assigned to an Assignee until written notice of such assignment, together with payment instructions, addresses, and related information with respect to the Assignee, have been given to Borrower by Bank and the Assignee. From and after the date that Bank provides Borrower with such written notice, the Assignee thereunder shall be a party hereto and, to the extent that rights and obligations hereunder have been assigned to it pursuant to such assignment, shall have the assigned and delegated rights and obligations of Bank
under the Loan Documents.

          (b)     Participations. Bank may at any time sell to one or more commercial banks, financial institutions, or other Persons, as Participants, an interest in the Obligations (including the Letter of Credit Obligations) and the other rights and interests of Bank hereunder and under the other Loan Documents; provided, however, that (i) Bank shall remain the “Bank” for all purposes of this Agreement and the other Loan Documents and the Participant receiving the participating interest in the Obligations and the other rights and interests of Bank shall not constitute a “Bank” hereunder or under the other Loan Documents and Bank’s obligations under this Agreement shall remain unchanged, (ii) Bank shall remain solely responsible for the performance of such obligations, (iii) Borrower and Bank shall continue to deal solely and directly with each other in
connection with Bank’s rights and obligations under this Agreement and the other Loan Documents, and (iv) all amounts payable by Borrower hereunder shall be determined as if Bank had not sold such participation, except that, if amounts outstanding under this Agreement are due and unpaid, or shall have been declared or shall have become due and payable upon the occurrence of an Event of Default, each Participant shall be deemed to have the right of set-off in respect of its participating interest in amounts owing under this Agreement to the same extent as if the amount of its participating interest were owing directly to it as Bank under this Agreement. The rights of any Participant only shall be derivative through Bank and no Participant shall have any rights under this Agreement or the other Loan Documents or any direct rights as to Borrower, the Collections, the Collateral, or otherwise in respect of the Obligations.

36

          (c)     Disclosures. In connection with any such assignment or participation or proposed assignment or participation, Bank may disclose all documents and information that it now or hereafter may have relating to Borrower or Borrower’s business, subject to the confidentiality requirements set forth in Section 8.18.

          Section 8.10     Setoff.  In addition to any rights now or hereafter granted under Applicable Law and not by way of limitation of any such rights, upon the occurrence of an Event of Default after the expiration of any cure period applicable thereto, if any, and until such Event of Default is waived in writing by Bank, Bank is hereby authorized by Borrower at any time or from time to time, without notice to Borrower, or to any other Person, any such notice being hereby expressly waived, to set off and to appropriate and to apply any and all deposits (general or special, time or demand, including, but not limited to, Indebtedness evidenced by certificates of deposit, in each case whether matured or unmatured) and any other Indebtedness at any time held or owing by Bank, its branches, Subsidiaries or affiliates, for the credit or the account of Borrower against and
on account of the obligations and liabilities of Borrower to Bank under this Agreement and any other Loan Document, including, but not limited to, all claims of any nature or description arising out of or connected with this Agreement or any other Loan Document, irrespective of whether or not (a) Bank shall have made any demand hereunder or (b) Bank shall have declared the principal of and interest on the Loans and the Agreement and other amounts due hereunder to be due and payable.

          Section 8.11     Revival and Reinstatement of Obligations.  If the incurrence or payment of the Obligations by Borrower or the transfer to Bank of any property should for any reason subsequently be declared to be void or voidable under any state or federal law relating to creditors’ rights, including provisions of the Bankruptcy Code relating to fraudulent conveyances, preferences, or other voidable or recoverable payments of money or transfers of property (collectively, a “Voidable Transfer”), and if Bank is required to repay or restore, in whole or in part, any such Voidable Transfer, or elects to do so upon the reasonable advice of its counsel, then, as to any such Voidable Transfer, or the amount thereof that Bank is required or elects to repay or restore, and as to all costs, expenses, and attorneys fees of Bank related thereto, the
liability of Borrower automatically shall be revived, reinstated, and restored and shall exist as though such Voidable Transfer had never been made.

          Section 8.12     Governing Law.  This Agreement shall be construed in accordance with and governed by the internal laws of the State of Florida applicable to agreements made and to be performed wholly within the State of Florida without reference to the conflicts of law provisions thereof that may cause the application of the laws of another jurisdiction.

          Section 8.13     Severability of Provisions.  Any provision of any Loan Document which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of such Loan Document or affecting the validity or enforceability of such provision in any other jurisdiction.

          Section 8.14     Entire Agreement.  Except as otherwise expressly provided herein, this Agreement, the Loan Documents, and the other documents described or contemplated herein embody the entire agreement and understanding between or among any of the parties hereto and thereto and supersede all prior agreements and understandings relating to the subject matter hereof and thereof between or among any of the parties hereto.

37

          Section 8.15     Conflicts.  In the event of any conflict between the provisions of this Agreement and the provisions of any other Loan Document, the terms and provisions of this Agreement shall control.

          Section 8.16     Counterparts.  This Agreement may be executed in multiple counterparts, each of which shall be deemed to be an original, but all such separate counterparts shall together constitute but one and the same instrument. Delivery of an executed counterpart by facsimile transmission shall be deemed equally effective as a manually executed counterpart hereof.

          Section 8.17     Headings.  Article and Section headings in this Agreement are for the convenience of reference only, and shall not constitute a part of this Agreement for any other purpose.

          Section 8.18     Confidentiality.  Bank agrees to take, and to cause its Affiliates to take, normal and reasonable precautions and exercise due diligence to maintain the confidentiality of all non-public information provided to it by Borrower or any Subsidiary under this Agreement, and neither the Bank nor its Affiliates shall use any such information other than in connection with or in enforcement of this Agreement or in connection with other business now or hereafter existing or contemplated with Borrower or any Subsidiary; except the extent such information (a) was or becomes generally available to the public other than as a result of disclosure by the Bank; (b) was or becomes available on a non-confidential basis from a source other than Borrower or any of its Affiliates referenced in clause (a) of the definition of “Affiliate,” provided that such
source is not bound by a confidentiality agreement with Borrower or any of such Affiliates of Borrower, provided, however, that Bank may disclose such information (i) at the request or pursuant to any requirement of any Governmental Authority to which Bank is subject or in connection with an examination of Bank by any such authority; (ii) pursuant to subpoena or other court process; (iii) to the extent reasonably required in connection with the exercise of any remedy hereunder; (iv) to the Bank’s independent auditors and other professional advisors; (v) to any Participant or Assignee, actual or potential (or their respective professional advisors), or to any counterparty (or its professional advisors) to any swap, securitization or derivative transaction referencing or involving any of its rights or obligations as a lender under this Agreement, actual or potential, provided that such Person agrees in writing to keep such information confidential to the same extent required of the bank hereunder;
and (vi) as expressly permitted under the terms of any other document or agreement to which Borrower or any Subsidiary is party with Bank or its Affiliates.

          Section 8.19     Consent to Jurisdiction.  ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF FLORIDA OR OF THE UNITED STATES FOR THE MIDDLE DISTRICT OF FLORIDA AND BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH OF BORROWER AND BANK CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE NONEXCLUSIVE JURISDICTION OF THOSE COURTS. EACH OF BORROWER AND BANK IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, THAT IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THIS AGREEMENT OR ANY DOCUMENT RELATED HERETO. BORROWER AND BANK EACH WAIVE PERSONAL SERVICE OF ANY SUMMONS, COMPLAINT, OR OTHER PROCESS, THAT MAY BE MADE BY ANY OTHER MEANS
PERMITTED BY APPLICABLE LAW.

38

          Section 8.20     Jury Trial Waiver.  TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH OF BANK AND BORROWER HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO ANY OF THE LOAN DOCUMENTS, THE BORROWINGS OR THE ACTIONS OF BANK IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT THEREOF.

          Section 8.21     Customer Identification - USA Patriot Act Notice.  The Bank hereby notifies the Borrower that, pursuant to the requirements of the USA Patriot Act, Title III of Pub. L. 107-56, signed into law October 26, 2001, as amended (the “Patriot Act”), the Bank is required to obtain, verify and record information that identifies Borrower, which information includes the name and address of Borrower and other information that will allow the Bank to identify Borrower in accordance with the Patriot Act.  

[SIGNATURES FOLLOW]

39

         IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first above written.

	  WITNESSES:
	  
	 “BORROWER”

	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
FARO   TECHNOLOGIES, INC.,
   a Florida corporation
  
	
  
 
  	
  
 
  	
  
 
  
	
  
______________________________
  	
  
 
  	
  
By:
  	
  
/s/ Jay W.   Freeland
  
	
  Print   Name:____________________
  	
  
 
  	
  
 
  	
  

  
	
  
 
  	
  
 
  	
  
 
  	
  
Jay W.   Freeland
  
	
  
 
  	
  
 
  	
  
 
  	
  
Co-Chief   Executive Officer, President, and Chief Operating Officer
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
______________________________
  	
  
 
  	
  
 
  	
  
(CORPORATE   SEAL)
  
	
  
Print   Name:____________________
  	
  
 
  	
  
 
  	
   
 
	
  Two witnesses as to   Borrower
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
“BANK”
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
SUNTRUST   BANK
  
	
  
 
  	
  
 
  	
  
 
  
	
  
______________________________
  	
  
 
  	
  
By:
  	
  
 /s/   Scott G. Balke
  
	
  
Print   Name:____________________
  	
  
 
  	
  
 
  	
  

  
	
   
  	
  
 
  	
  
 
  	
  
Scott G.   Balke
  
	
  
 
  	
  
 
  	
  
 
  	
  
First Vice   President
  
	
  
______________________________
  	
  
 
  	
  
 
  	
  
 
  
	
  
Print   Name:____________________
  	
  
 
  	
  
 
  	
  
 
  
	
  
Two witnesses as to Bank
  	
  
 
  	
  
 
  	
  
 
  

40

EXHIBIT A

FORM OF PROMISSORY NOTE

	
  
$30,000,000
  	
  
July 11, 2006
  

          
BEING INDEBTED FOR VALUE RECEIVED, the undersigned, FARO TECHNOLOGIES, INC., a
Florida corporation (the “Borrower”), promises to pay to
SUNTRUST BANK (the “Bank”), or order, in the manner hereinafter
specified, the principal sum of THIRTY MILLION DOLLARS ($30,000,000), together
with interest thereon from time to time from the date hereof until paid in full
at the interest rate set forth in the Loan Agreement (as defined below). Said
principal and interest shall be payable in lawful money of the United States of
America at 200 South Orange Avenue, Orlando, Florida 32801, or at such other
place as may hereafter be designated by written notice from the holder
(“Holder”) of this instrument to Borrower, on the dates and in
the manner set forth in the Loan Agreement.

          This Note is the Note referred to in, and is entitled to the benefits of, that certain Loan Agreement of even date herewith by and between Borrower and Bank (the “Loan Agreement”), the terms of which are incorporated herein by this reference. This Note is secured by, among other things, that certain Security Agreement of even date herewith executed and delivered by Borrower in favor of Bank (the “Security Agreement”) and the Pledge Agreement dated as of September 17, 2003, as amended, executed and delivered by Borrower in favor of the Bank and reaffirmed by the Borrower as of date hereof (the “Pledge Agreement”) reference to each of which is hereby made for a description of the Collateral provided for under the Security Agreement and the Pledge Agreement and the rights of Borrower and Bank with respect to such Collateral. Terms used herein without
definition shall have the meanings ascribed thereto in the Loan Agreement, and if not defined therein, in the Security Agreement.

          This Note may be prepaid in whole or in part in accordance with the terms and provisions set forth in the Loan Agreement, and is subject to mandatory prepayment in accordance with the terms of the Loan Agreement.

          Payments of principal and interest hereunder shall be paid in accordance with the Loan Agreement. Any installment of principal or interest due under this Note that is not paid in full on the due date therefor, whether a regularly scheduled payment date, on the Maturity Date, or otherwise resulting from the acceleration of maturity upon the occurrence of an Event of Default, shall bear interest from the due date until payment in full as provided in Section 2.08 of the Loan Agreement.

          Upon the occurrence of any one or more of the Events of Default specified in the Loan Agreement, or in any other document or instrument delivered in connection therewith, interest shall accrue on all amounts outstanding at the Default Rate and all amounts then remaining unpaid on this Note may be declared to be immediately due and payable as provided in the Loan Agreement.

A-1

          Borrower grants to Holder a security interest in, and hereby assigns, conveys, delivers, pledges, and transfers to Holder all of Borrower’s right, title, and interest in and to Borrower’s accounts with Holder (whether checking, savings, or other account), including accounts Borrower may open in the future, excluding, however, all trust accounts for which the grant of a security interest would be prohibited by law. Borrower authorizes Holder, to the extent permitted by applicable law, to charge or set-off all sums owing on the indebtedness evidenced by this Note against any and all such accounts. Said right of set-off may also be exercised and applicable where Holder is indebted to any signer hereof by reason of any certificate of deposit, note or otherwise.

          Borrower and all persons liable or to become liable on this Note agree, jointly and severally, to pay all costs of collection, including reasonable attorney’s fees and all costs of suit, in case any payment of principal and/or interest required herein is not paid when due, or in case it becomes necessary to protect or foreclose the security for the indebtedness evidenced hereby, or in the event the Holder is made party to any litigation because of the existence of the indebtedness evidenced by this Note or any agreement executed by Borrower in connection with the loan evidenced hereby, whether suit be brought or not, and whether through courts of original jurisdiction, as well as in courts of appellate jurisdiction, or through a Bankruptcy Court or other legal proceedings. Demand, presentment, protest, notice of protest and notice of dishonor are hereby waived by Borrower.

          Notwithstanding anything contained herein to the contrary, the interest rate charged pursuant to this Note including all charges and fees in connection therewith deemed in the nature of interest under Florida law, shall not exceed the maximum rate allowed by law. In the event the stated interest rate on the Notes together with any other charge or fee deemed in the nature of interest exceeds the maximum legal rate, then, ipso facto, the interest rate shall be reduced to the maximum legal rate, and if, interest in excess of the maximum legal rate shall have been paid by Borrower in connection with this Note or under the other Notes, the amount of such excess shall be applied to unpaid and outstanding principal, and not to the payment of interest.

          Borrower hereby consents and agrees that, in any actions predicated upon this Note, venue is properly laid in Orange County, Florida and that the Circuit Court in and for Orange County, Florida or the Federal Court for the Middle District of Florida shall have full jurisdiction to determine all issues arising out of or in connection with the execution and enforcement of this Note. Borrower waives to the fullest extent for itself, its successors and assigns and all persons now or at any time liable for payment of this Note, to the fullest extent permitted under the laws of the State of Florida, any right, power, privilege or prerogative to demand a jury trial with respect to any and all issues arising out of or in connection with the execution, delivery and/or enforcement of this Note or the transactions contemplated in the other Loan Documents (including but not limited to any claims, cross-claims or
third party claims).

          BORROWER REPRESENTS AND WARRANTS TO BANK THAT THE LOAN AND ALL PROCEEDS FROM THIS NOTE SHALL BE USED SOLELY FOR BUSINESS OR COMMERCIAL PURPOSES.

A-2

          THIS INSTRUMENT IS BEING EXECUTED AND DELIVERED FOR THE PURPOSE OF RENEWING THAT CERTAIN PROMISSORY NOTE DATED SEPTEMBER 17, 2003, AS HERETOFORE RENEWED AS OF AUGUST 31, 2004 AND AS OF AUGUST 31, 2005, AND ON WHICH THE FULL AMOUNT OF DOCUMENTARY STAMP TAX WAS PAID PURSUANT TO SECTION 201.09(1)(a), FLORIDA STATUTES.  A COPY OF THE ORIGINAL NOTE SHOWING THE DOCUMENTARY STAMP TAX PAID IS ATTACHED HERETO.  NO NEW OBLIGORS HAVE BEEN ADDED.  NO ADDITIONAL DOCUMENTARY STAMP TAX IS DUE ON THIS INSTRUMENT PURSUANT TO SECTION 201.09(1), FLORIDA STATUTES.

	  Borrower’s Address:
	 “BORROWER”

	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	

  
  FARO   TECHNOLOGIES, INC., a Florida corporation

	
   
  	
  
 
  	
  
 
  
	
  
125   Technology Park
  	
  
 
  	
  
 
  
	
  
Lake Mary,   Florida  32746
  	
  
 
  	
  
 
  
	
  
 
  	
  
By:
  	
  
/s/ Jay W.   Freeland
  
	
  
 
  	
  
 
  	
  

  
	
  
 
  	
  
 
  	
  
Jay W.   Freeland
  
	
  
 
  	
  
 
  	
  
Co-Chief   Executive Officer, President,
  
	
  
 
  	
  
 
  	
  
and Chief   Operating Officer
  
	
   
  	
   
  	
   
  
	
   
  	
   
  	
  (CORPORATE SEAL)
  

A-3

TABLE OF CONTENTS

	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   I  DEFINITIONS AND ACCOUNTING TERMS
  	
  
 
  	
  
1
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 1.01
  	
  
Defined   Terms
  	
  
 
  	
  
1
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 1.02
  	
  
Accounting   Terms
  	
  
 
  	
  
12
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   II  AMOUNT AND TERMS OF THE LOAN
  	
  
 
  	
  
12
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.01
  	
  
The Loans
  	
  
 
  	
  
12
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.02
  	
  
Notice and   Manner of Borrowing for Loans
  	
  
 
  	
  
13
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.03
  	
  
The Note
  	
  
 
  	
  
13
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 2.04
  	
  
Fees
  	
  
 
  	
  
13
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.05
  	
  
Interest   Rate for Loans
  	
  
 
  	
  
13
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.06
  	
  
Savings   Clause
  	
  
 
  	
  
14
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.07
  	
  
Interest   Payments on Loans
  	
  
 
  	
  
14
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.08
  	
  
Late   Payments and Default Rate
  	
  
 
  	
  
14
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 2.09
  	
  
Optional   Prepayments
  	
  
 
  	
  
14
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.10
  	
  
Mandatory   Repayments
  	
  
 
  	
  
14
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.11
  	
  
Method of   Payment
  	
  
 
  	
  
15
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.12
  	
  
Application   of Payments
  	
  
 
  	
  
15
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.13
  	
  
Demand,   Maturity Date
  	
  
 
  	
  
15
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 2.14
  	
  
Use of   Proceeds
  	
  
 
  	
  
15
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.15
  	
  
Illegality
  	
  
 
  	
  
16
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.16
  	
  
Increased   Cost
  	
  
 
  	
  
16
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.17
  	
  
Funding Loss   Indemnification
  	
  
 
  	
  
16
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.18
  	
  
Letter of   Credit Subfacility
  	
  
 
  	
  
17
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 2.19
  	
  
Conflict   with Letter of Credit Documents
  	
  
 
  	
  
19
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 2.20
  	
  
Cash   Management
  	
  
 
  	
  
19
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   III  CONDITIONS PRECEDENT
  	
  
 
  	
  
19
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 3.01
  	
  
Condition   Precedent
  	
  
 
  	
  
19
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 3.02
  	
  
Conditions   to All Extensions of Credit
  	
  
 
  	
  
21
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  ARTICLE   IV  REPRESENTATIONS AND WARRANTIES
  	
  
 
  	
  
21
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.01
  	
  
Incorporation,   Good Standing and Due Qualification
  	
  
 
  	
  
22
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.02
  	
  
Corporate   Power and Authority
  	
  
 
  	
  
22
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.03
  	
  
Legally   Enforceable Agreement
  	
  
 
  	
  
22
  

i

	
  
 
  	
  
Section 4.04
  	
  
Consents
  	
  
 
  	
  
22
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 4.05
  	
  
Financial   Statements
  	
  
 
  	
  
22
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.06
  	
  
Labor   Disputes and Acts of God
  	
  
 
  	
  
23
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.07
  	
  
Litigation
  	
  
 
  	
  
23
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.08
  	
  
No Defaults   on Outstanding Judgments or Orders
  	
  
 
  	
  
23
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.09
  	
  
Ownership   and Liens
  	
  
 
  	
  
23
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 4.10
  	
  
Subsidiaries
  	
  
 
  	
  
23
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.11
  	
  
ERISA
  	
  
 
  	
  
23
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.12
  	
  
Operation of   Business
  	
  
 
  	
  
24
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.13
  	
  
Taxes
  	
  
 
  	
  
24
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.14
  	
  
Environmental
  	
  
 
  	
  
24
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 4.15
  	
  
Indebtedness
  	
  
 
  	
  
24
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.16
  	
  
Investments   in Subsidiaries; Intercompany Loans and Advances
  	
  
 
  	
  
24
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.17
  	
  
Solvency
  	
  
 
  	
  
24
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.18
  	
  
Other   Agreements
  	
  
 
  	
  
24
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 4.19
  	
  
No   Materially Misleading Facts
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  ARTICLE   V  AFFIRMATIVE COVENANTS
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.01
  	
  
Maintain   Existence
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.02
  	
  
Maintain   Books and Records
  	
  
 
  	
  
25
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.03
  	
  
Maintain   Properties
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.04
  	
  
Conduct of   Business
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 5.05
  	
  
Maintain   Insurance
  	
  
 
  	
  
25
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.06
  	
  
Compliance   With Laws
  	
  
 
  	
  
26
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.07
  	
  
Payment of   Taxes and Indebtedness
  	
  
 
  	
  
26
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.08
  	
  
Right of   Inspection
  	
  
 
  	
  
26
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.09
  	
  
Further   Assurances
  	
  
 
  	
  
26
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 5.10
  	
  
Use of   Proceeds
  	
  
 
  	
  
26
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.11
  	
  
Environment
  	
  
 
  	
  
26
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.12
  	
  
Reporting   Requirements
  	
  
 
  	
  
27
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 5.13
  	
  
Financial   Covenants
  	
  
 
  	
  
28
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   VI  NEGATIVE COVENANTS
  	
  
 
  	
  
28
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.01
  	
  
Liens
  	
  
 
  	
  
28
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.02
  	
  
Indebtedness
  	
  
 
  	
  
29
  

ii

	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.03
  	
  
Subsidiaries;   Mergers; Reorganizations and Permitted Acquisitions of Domestic Subsidiaries
  	
  
 
  	
  
29
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.04
  	
  
Sale and   Leaseback
  	
  
 
  	
  
29
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.05
  	
  
Dividends
  	
  
 
  	
  
29
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 6.06
  	
  
No   Impairment of Intercompany Payments
  	
  
 
  	
  
29
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.07
  	
  
Asset Sales
  	
  
 
  	
  
30
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.08
  	
  
Investments   and Intercompany Loans and Advances
  	
  
 
  	
  
30
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.09
  	
  
Guarantees
  	
  
 
  	
  
30
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 6.10
  	
  
Transactions   With Affiliates
  	
  
 
  	
  
30
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 6.11
  	
  
Financial   Covenants
  	
  
 
  	
  
30
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   VII  EVENTS OF DEFAULT AND REMEDIES
  	
  
 
  	
  
30
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 7.01
  	
  
Events of   Default
  	
  
 
  	
  
30
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 7.02
  	
  
Remedies
  	
  
 
  	
  
32
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 7.03
  	
  
Cash   Collateralization of Letters of Credit
  	
  
 
  	
  
33
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 7.04
  	
  
Grant of   Royalty-Free License Following Event of Default
  	
  
 
  	
  
33
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
ARTICLE   VIII  MISCELLANEOUS
  	
  
 
  	
  
33
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.01
  	
  
Effectiveness
  	
  
 
  	
  
33
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.02
  	
  
Amendments   and Waivers
  	
  
 
  	
  
34
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.03
  	
  
Notices
  	
  
 
  	
  
34
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 8.04
  	
  
No Waiver
  	
  
 
  	
  
35
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.05
  	
  
Successors   and Assigns
  	
  
 
  	
  
35
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.06
  	
  
Costs,   Expenses, and Taxes
  	
  
 
  	
  
35
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.07
  	
  
Integration
  	
  
 
  	
  
35
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.08
  	
  
Indemnity
  	
  
 
  	
  
35
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 8.09
  	
  
Assignments;   Participations
  	
  
 
  	
  
36
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.10
  	
  
Setoff
  	
  
 
  	
  
37
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.11
  	
  
Revival and   Reinstatement of Obligations
  	
  
 
  	
  
37
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.12
  	
  
Governing   Law
  	
  
 
  	
  
37
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.13
  	
  
Severability   of Provisions
  	
  
 
  	
  
37
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
   
  	
  
Section 8.14
  	
  
Entire   Agreement
  	
  
 
  	
  
37
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.15
  	
  
Conflicts
  	
  
 
  	
  
38
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.16
  	
  
Counterparts
  	
  
 
  	
  
38
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
 
  	
  
Section 8.17
  	
  
Headings
  	
  
 
  	
  
38
  

iii

	
  
 
  	
  
Section 8.18
  	
  
Confidentiality
  	
  
 
  	
  
38
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
Section 8.19
  	
  
Consent to   Jurisdiction
  	
  
 
  	
  
38
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
Section 8.20
  	
  
Jury Trial   Waiver
  	
  
 
  	
  
39
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
Section 8.21
  	
  
Customer   Identification – USA Patriot Act Notice
  	
  
 
  	
  
39
  

iv

U.S. $30,000,000

AMENDED AND RESTATED
 LOAN AGREEMENT

by and between

FARO TECHNOLOGIES, INC.,

as Borrower

and

SUNTRUST BANK
 as the Bank,

Dated as of July 11, 2006Employment Agreement

    

    -3-

     

    EXECUTIVE
      EMPLOYMENT AGREEMENT 

     

    ASPREVA
      PHARMACEUTICALS CORPORATION

     

    PRIVATE
      AND CONFIDENTIAL

     

    November
      1, 2005

    Richard
      Jones 

    19,
      Chlupfgasse 

    Bassersdorf
      CH 8303

     

    Dear
      Richard:

     

    Re:    
Terms
      of
      Employment with ASPREVA PHARMACEUTICALS CORPORATION (the "Corporation")

     

    This
      Agreement confirms the terms and conditions of your employment by the
      Corporation and will
      constitute your employment agreement. Those terms and conditions are set out
      below:

     

    Position
      and Duties.
      You
      will be employed by and will serve the Corporation as its Senior Vice President,
      Search,
      Discovery and Evaluation and a member of the corporation's executive management
      team,
      having the duties and functions customarily performed by, and have all
      responsibilities customary
      to, a Senior Vice President, Search, Discovery and Evaluation of a corporation
      engaged
      in a business similar to that of the Corporation, including those duties and
      functions particularly described in Schedule A attached to this Agreement.
      You
      will report directly to the President
      of the Corporation. Your duties and functions pertain to the Corporation and
      any
      of its subsidiaries
      from time to time and may be varied or added to from time to time by the
      President, at
      his
      discretion, exercised reasonably.

     

    
      	
            	
              1.

            	
              Term.
                The terms and conditions of this Agreement shall have effect as of
                and
                from 1st
                March, 2006
                (the "Effective
                Date") and
                your employment as Senior Vice President, Search, Discovery and
                Evaluation of the Corporation shall continue for a period of 4 years,
                renewable thereafter by mutual written agreement of the parties for
                successive one year terms, or until earlier terminated as
                provided in this Agreement.

            

    

     

    
      	
            	
              2.

            	
              Base
                Salary.
                The Corporation shall pay you a base salary at the rate of $290,000
                CDN
                per year (the
                "Base
                Salary"), payable
                semi-monthly, subject to the withholding of all applicable statutory
                deductions
                from such Base Salary and including any taxable benefits received
                under
                this Agreement
                or in respect of your employment.

            

    

     

    
      	
            	
              3.

            	
              Signing
                Bonus.
                One month after joining the Corporation, upon both parties executing
                this
                Agreement,
                the Corporation shall pay to you a one-time signing bonus (the
                "Signing
                Bonus") of
                $15,000 CDN, subject to the withholding of all applicable statutory
                deductions in respect of such Signing
                Bonus. You shall be required to promptly repay the Signing Bonus
                to the
                Corporation if you
                terminate your employment pursuant to Section 15 (Termination by
                Executive) within 2 years following the Effective Date. In addition,
                the
                Corporation shall have the right to set off the Signing Bonus
                against any amounts owed by the Corporation to you on the effective
                date
                of termination of
                your employment.

            

    

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -4-

     

    
      	
              4.

            	
              Annual
                Review.
                The compensation committee (the "Compensation
                Committee") established
                by the Board of Directors (the "Board")
                of
                the Corporation for the purposes of this Agreement shall review your
                Base
                Salary annually. This review shall not result in a decrease of your
                Base
                Salary nor shall it necessarily result in an increase in your Base
                Salary
                and any increase shall be in the discretion
                of the Board.

            

    

     

    
      	
              5.

            	
              Performance
                Bonus.
                The Corporation shall review the performance of your duties and functions
                under
                this Agreement annually and shall pay you a bonus of up to 30% of
                your
                Base Salary if the Board,
                in its sole discretion, determines that certain short-term and long-term
                business performance
                objectives of the Corporation and objectives related to your personal
                performance (together,
                the "Objectives"),
                respectively
                weighted 40% and 60%, have been achieved. The Objectives
                will be established from time to time by the Board or the Compensation
                Committee after
                consultation with you. Payment of the performance bonus set out in
                this
                Section 5 shall be made
                to you within a reasonable time following the end of each fiscal
                year and
                shall be subject to the
                withholding of all applicable statutory deductions by the
                Corporation.

            

    

     

    
      	
              6.

            	
              Benefits.
                The Corporation will arrange for you to be provided with health,
                medical,
                dental, accident
                and life insurance and such other benefits as are reasonable and
                appropriate for an executive
                level benefits plan, as determined by the Board from time to time,
                based
                on the recommendations
                of the Compensation Committee after consultation with you. These
                benefits
                will
                be consistent with other Senior Vice Presidents and will be comparable
                to
                those set out below in
                Exhibit B. You may be required to provide information and undergo
                reasonable assessments of the
                applicable insurer in order to determine your eligibility for benefits
                coverage. You acknowledge
                and agree that coverage under any benefit plan in effect from time
                to time
                is subject to
                availability and other requirements of the applicable insurer and
                the
                Corporation makes no promise
                about your eligibility for or entitlement to benefits and will have
                no
                liability or responsibility
                in the event you are denied coverage. You further acknowledge and
                agree
                that the components
                of the benefits package may be amended, modified or terminated from
                time
                to time by
                the Corporation in its sole discretion, and this may include terminating
                or changing carriers.

            

    

     

    
      	
              7.

            	
              Vacation.
                During your employment with the Corporation under this Agreement,
                you will
                be entitled
                to an annual paid vacation as determined by the Corporation from
                time to
                time, not less than
                20 days per annum, plus up to three days company designated days
                and
                within policy guidelines
                up to 3 days paid parental leave. The Corporation reserves the right,
                acting reasonably,
                to request that vacations be scheduled so as not to conflict with
                critical
                business operations.

            

    

     

    
      	
              8.

            	
              Relocation
                and Reimbursement.
                You acknowledge and agree that the Corporation's head office is
                located in the metropolitan area of Victoria, British Columbia and
                that
                the principal place of your employment
                is at such head office. You shall relocate your principal residence
                from
                Bassersdorf, Zurich, to a new location in the metropolitan area of
                Victoria, British Columbia upon commencing employment
                with the Corporation under this Agreement. In consideration of your
                agreement to relocate
                your principal residence, the Corporation shall reimburse you for
                the cost
                of one house- hunting
                trip to Victoria for you and your spouse and shall provide to you
                the
                following amounts (the
                "Relocation
                Allowance") associated
                with your move:

            

    

    

     

    
      	 	
              (a)

            	
              reasonable
                moving expenses to a maximum of $35,000 CDN incurred by you to relocate
                you and your spouse and family, plus personal possessions from
                Bassersdorf, Zurich to your
                new residence in the metropolitan area of Victoria, British Columbia,
                subject to receipt
                by the Corporation of the applicable invoice or invoices for such
                expenses; to be used
                over a period of no more than 2
                years;

            

    

     

    
      	 	
              (b)

            	
              professional
                fees for the first three years related to tax advice provided by
                accountants of your
                choice to a maximum of $3,000 CDN in year 1, $2,000 CDN in year 2
                and
                $1,000 CDN
                in year 3 and;

            

    

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -5-

     

    Should
      you resign your employment with the Corporation pursuant to Section 17 or be
      terminated for
      Cause pursuant to Section 19 in the first three (3) years of your employment
      with the Corporation,
      you agree to repay the Relocation Allowance to the Corporation in accordance
      with the
      following schedule:

     

    
      	
              Years
                of Employment

            	
              Repayment
                of Relocation Allowance

            
	 	 
	
              0-1
                year

            	
              Full
                repayment of Relocation Allowance

            
	 	 
	
              1
                -2 years

            	
              Repayment
                of 2/3 of Relocation Allowance

            
	 	 
	
              2-3
                years

            	
              Repayment
                of 1/3 of Relocation Allowance

            
	 	 
	
              after
                3 years

            	
              Nil

            

    

     

    
      	
              9.

            	
              Reimbursement
                for Expenses.
                During your employment under this Agreement, the Corporation shall
                reimburse you for reasonable travelling and other expenses actually
                and
                properly incurred by you in connection with the performance of your
                duties
                and functions, such reimbursement to be
                made in accordance with, and subject to, the policies of the Corporation
                from time to time. For all
                such expenses you will be required to keep proper accounts and to
                furnish
                statements, vouchers,
                invoices and/or other supporting documents to the
                Corporation.

            

    

     

    
      	
              10.

            	
              Stock
                Options.
                You will receive 100,000 stock options at an exercise price and on
                such
                other terms
                set forth in the Aspreva 2002 Incentive Stock Option Plan, subject
                to
                approval of the Board and
                applicable securities regulatory authorities and to execution and
                delivery
                by you of a stock option
                agreement in a form acceptable to the Corporation. The stock options
                shall, vest and be exercisable
                in the following way:

            

    

     

    (a) No
      options will vest for the first year (12 months) following the
      grant;

     

    
      	 	
              (b)

            	
              options
                will begin to vest at the rate of 1 /36th
                of the grant, each month at the end of each month (for a period of
                36
                months).

            

    

     

    
      	 	
              (c)

            	
              All
                options from this grant will be vested at the end of the 36 months,
                following the initial 12
                month waiting period.

            

    

     

    The
      options granted in this Section 10 will cease to vest:

     

    
      	 	
              (d)

            	
              on
                the date you provide the Corporation with written notice of your
                decision
                to resign your employment pursuant to Section 15 (Termination by
                Executive);

            

    

     

    
      	 	
              (e)

            	
              on
                the date the Corporation provides you with written notice of its
                decision
                to terminate your
                employment pursuant to Section 16 (Termination without
                Cause);

            

    

     

    
      	 	
              (f)

            	
              on
                the date the Corporation terminates your employment pursuant to Section
                17
                (Termination
                for Cause); or

            

    

     

    (g) otherwise
      on the date this Agreement is terminated or deemed terminated.

     

    For
      greater certainty, neither the period of notice nor any payment in lieu thereof
      will be considered
      as extending the period of your employment with respect to the vesting or
      exercise of the options granted in this Section 10.

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -6-

     

    In
      accordance with Section 6.5 of the Aspreva 2002 Incentive Stock Option Plan,
      should your employment with the Corporation end pursuant to Section 16 or 17
      of
      this agreement, you will have
      three (3) months from the date your employment ended to exercise your vested
      stock options,
      failing which these options shall expire. Should your employment with the
      Corporation end
      pursuant to Section 18 of this agreement, your options shall expire on the
      date
      your employment
      was terminated.

     

    
      	
              11.

            	
              Compliance
                with Insider Trading Guidelines and Restrictions.
                As a result of your position as Senior
                Vice President, Search, Discovery and Evaluation, you are subject
                to
                insider trading regulations
                and restrictions and are required to file insider reports disclosing
                the
                grant of any options as well as the purchase and sale of any shares
                in the
                capital of the Corporation. The Corporation
                may from time to time publish trading guidelines and restrictions
                for its
                employees, officers
                and directors as are considered by the Board, in its discretion,
                prudent
                and necessary for a
                publicly listed company. It is a term of your employment as a senior
                officer of the Corporation that
                you comply with such guidelines and
                restrictions.

            

    

     

    
      	
              12.

            	
              Directors'
                & Officers' Liability Insurance.
                The Corporation shall use commercially reasonable efforts to provide
                you
                with directors' and officers' liability insurance under the policies
                for
                such insurance
                arranged by the Corporation from time to time upon such terms and
                in such
                amounts as
                the Board may reasonably determine in its
                discretion.

            

    

     

    
      	
              13.

            	
              No
                Other Compensation or Benefits.
                You expressly acknowledge and agree that unless otherwise
                expressly agreed in writing by the Corporation subsequent to execution
                of
                this Agreement
                by the parties hereto, you shall not be entitled by reason of your
                employment by the Corporation
                or by reason of any termination of such employment, to any remuneration,
                compensation
                or benefits other than as expressly set forth in this
                Agreement.

            

    

     

    14.     Service
      to Employer.
      During your employment under this Agreement you will:

    

     

    
      	 	
              (a)

            	
              well
                and faithfully serve the Corporation, at all times act in, and promote,
                the best interests
                of the Corporation, and devote substantially the whole of your working
                time, attention
                and energies to the business and affairs of the
                Corporation;

            

    

     

    
      	 	
              (b)

            	
              comply
                with all reasonable rules, regulations, policies and procedures of
                the
                Corporation; and

            

    

     

    
      	 	
              (c)

            	
              not,
                without the prior approval of the Board, to carry on or engage in
                any
                other business or occupation or become a director, officer, employee
                or
                agent of or hold any position or office
                with any other corporation, firm or person, except as a volunteer
                for a
                non-profit organization,
                for personal investments or a personal holding company, which may
                include
                members of your family as
                shareholders.

            

    

     

    15.     Termination
      By Executive

     

    (a)         Subject
      to Section 19
      (Termination Following Change in Control), you may resign as Senior
      Vice President, Search, Discovery and Evaluation at any time, but only by giving
      the
      Corporation at least 3 months' prior written notice of the effective date of
      your resignation. On the giving of any such notice, the Corporation shall have
      the right to elect,
      in lieu of the notice period, to pay you a lump sum equal to 3 months' Base
      Salary, as
      referred to in Section 2 (Base Salary) and as adjusted from time to time in
      accordance with Section 4 (Annual Review), plus other sums owed for arrears
      of
      salary, vacation pay and, if granted pursuant to Section 5 (Performance Bonus),
      bonus.

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -7-

     

    (b)         If
      the Corporation
      elects to pay you such lump sum in lieu of the 3 months' notice period,
the
      Corporation shall, subject to the terms and conditions of any benefit plans
      in
      effect from time to time, maintain the benefits and payments set out in Section
      6 (Benefits) of this
      Agreement for 3 months after the date of your notice, but in all other respects,
      your resignation
      and the termination of your employment will be effective immediately upon
your
      receipt of the lump sum.

     

    16. Termination
      by the Corporation Without Cause.

     

    
      	 	
              (a)

            	
              The
                Corporation may terminate your employment as Senior Vice President,
                Search, Discovery
                and Evaluation at any time without Cause (as defined below) by giving
                you
                written
                notice of such termination and in all respects, except as set out
                below,
                the termination
                of your employment will be effective immediately upon your receipt
                of such
                notice.
                If you are a director of the Corporation you will be deemed to have
                resigned as a director,
                effective upon your receipt of the notice of termination without
                any
                further action on
                your part.

            

    

     

    
      	 	
              (b)

            	
              If
                your employment is terminated by the Corporation pursuant to this
                Section
                16, the Corporation
                shall pay to you as a lump sum the number of months of Base Salary,
                as
                referred
                to in Section 2 (Base Salary) and as adjusted from time to time in
                accordance with
                Section 4 (Annual Review) set out in the table below depending upon
                the
                year of employment
                in which you are terminated, plus such other sums owed for arrears
                of
                salary,
                vacation pay and, if granted pursuant to Section 5 (Performance Bonus),
                bonus:

            

    

    
    

     

    
      	
              Year
                of Employment

            	
              Lump
                Sum Payment of Base Salary (as adjusted)

            
	 	 
	
              1-2

            	
              6
                months

            
	 	 
	
              after
                2

            	
              12
                months

            

    

     

    
      	 	
              (c)

            	
              To
                the extent permitted by law and subject to the terms and conditions
                of any
                benefit plans
                in effect from time to time, the Corporation shall maintain the benefits
                and payments
                set out in Section 6 (Benefits) of this Agreement (the "Maintenance
                Payments")
                during
                a period of 6 months following
                termination.

            

    

     

    
      	 	
              (d)

            	
              The
                payments of Base Salary and benefits set out in this Section 16 shall
                be
                in lieu of any
                applicable notice period.

            

    

     

    
      	 	
              (e)

            	
              To
                the extent permitted by law, these terms will remain in effect, until
                or
                unless any more favourable terms have or will be offered to you or
                other
                senior officers of the company, at which point those more favourable
                terms
                will be deemed to form part of this
                agreement.

            

    

     

    
      	
              17.

            	
              Termination
                by the Corporation for Cause.
                Notwithstanding Section 15 (Termination by Executive),
                Section 16 (Termination by the Corporation Without Cause), or Section
                19
                (Termination
                Following Change of Control), the Corporation may terminate your
                employment as Senior Vice President, Search, Discovery and Evaluation
                for
                Cause upon written notice of such termination
                at any time without any notice or severance. In this Agreement,
                "Cause"
                shall
                include, but
                not be limited to, the following:

            

    

     

    (a)         the
      commission of
      theft, embezzlement, fraud, obtaining funds or property under false pretences
      or similar acts of misconduct with respect to the property of the Corporation
      or
      its employees or the Corporation's customers or suppliers;

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -8-

    

    
      	 	
              (b)

            	
              your
                entering of a guilty plea or conviction for any crime involving fraud,
                misrepresentation
                or breach of trust, or for any serious criminal offence that impacts
                adversely
                on the Corporation; or

            

    

     

    (c)      
any
      other matter constituting just cause at common law.

     

    any
      of
      which shall entitle the Corporation to terminate your employment under this
      Section 17. If you
      are
      a director of the Corporation you will be deemed to have resigned as a director,
      effective upon
      your receipt of the notice of termination without any further action on your
      part.

     

    
      	
              18.

            	
              Termination
                Following Change in Control.
                Concurrently with execution and delivery of this Agreement,
                you and the Corporation shall enter into a "Change of Control Agreement"
                in the form attached
                hereto as Schedule B setting out the compensation provisions to be
                applicable in the event of the termination of your employment as
                Senior
                Vice President, Search, Discovery and Evaluation
                of the Corporation in certain circumstances following a "Change in
                Control" of the Corporation
                (as defined in the Change of Control Agreement), and will remain
                the same
                as the treatment
                of all other senior officers.

            

    

     

    
      	
              19.

            	
              No
                Additional Compensation upon Termination.
                It is agreed that neither you nor the Corporation shall,
                as a result of the termination of your employment, be entitled to
                any
                notice, fee, salary, bonus,
                severance or other payments, benefits or damages arising by virtue
                of, or
                in any way relating
                to, your employment or any other relationship with the Corporation
                (including termination of
                such employment or relationship) in excess of what is specified or
                provided for in Section 15 (Termination
                by Executive), Section 16 (Termination by the Corporation Without
                Cause),
                Section 17
                (Termination by the Corporation for Cause), or Section 19 (Termination
                Following Chance in Control),
                whichever is applicable. Payment of any amount whatsoever pursuant
                to
                Section 15 (Termination
                by Executive), Section 16 (Termination by the Corporation Without
                Cause),
                Section 17
                (Termination by the Corporation for Cause), or Section 19 (Termination
                Following Change in Control)
                shall be subject to the withholding of all applicable statutory deductions
                by the Corporation.

            

    

     

    
      	
              20.

            	
              Confidentiality
                and Assignment of Inventions.
                Concurrently with execution and delivery of this Agreement
                and in consideration of your employment by the Corporation, you and
                the
                Corporation will
                enter into a "Confidentiality Agreement and Assignment of inventions"
                in
                the form attached hereto
                as Schedule C.

            

    

     

    
      	
              21.

            	
              Disclosure
                of Conflicts of Interest.
                During your employment with the Corporation, you will promptly,
                fully and frankly disclose to the Corporation in
                writing:

            

    

    

     

    
      	 	
              (a)

            	
              the
                nature and extent of any interest you or your Associates (as hereinafter
                defined) have or
                may have, directly or indirectly, in any contract or transaction
                or
                proposed contract or transaction
                of or with the Corporation or any subsidiary or affiliate of the
                Corporation;

            

    

     

    
      	 	
              (b)

            	
              every
                office you may hold or acquire, and every property you or your Associates
                may possess
                or acquire, whereby directly or indirectly a duty or interest might
                be
                created in conflict
                with the interests of the Corporation or your duties and obligations
                under
                this Agreement;
                and

            

    

     

    (c)       the
      nature and extent of any conflict referred to in subsection (b)
      above.

     

    In
      this
      Agreement the expression "Associate"
      shall
      include all those persons and entities that are included
      within the definition or meaning of "associate" as set forth in Section 1(1)
      of
      the Company
      Act (British
      Columbia), as amended, or any successor legislation of similar force and effect,
      and shall also include your spouse, children, parents, brothers and
      sisters.

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -9-

     

    
      	
              22.

            	
              Avoidance
                of Conflicts of Interest.
                You acknowledge that it is the policy of the Corporation that all
                interests
                and conflicts of the sort described in Section 21 (Disclosure of
                Conflicts
                of Interest) be avoided, and you agree to comply with all policies
                and
                directives of the Board from time to time regulating, restricting
                or
                prohibiting circumstances giving rise to interests or conflicts of
                the
                sort described in Section 21 (Disclosure of Conflicts of Interest).
                During
                your employment with the Corporation,
                without Board approval, in its sole discretion, you shall not enter
                into
                any agreement, arrangement
                or understanding with any other person or entity that would in any
                way
                conflict or interfere with this Agreement or your duties or obligations
                under this Agreement or that would otherwise
                prevent you from performing your obligations hereunder, and you represent
                and warrant
                that you or your Associates have not entered into any such agreement,
                arrangement or understanding,
                provided however you will be permitted to accept teaching or academic
                activities appointments
                as long as such activities related to such appointments do not conflict
                or
                hinder the performance of your
                duties.

            

    

     

    23.     Provisions
      Reasonable.
      It is
      acknowledged and agreed that:

     

    
      	 	
              (a)

            	
              both
                before and since the Effective Date the Corporation has operated
                and
                competed and
                will operate and compete in a global market, with respect to the
                business
                of the Corporation
                set out in Schedule D attached hereto (the "Business");

            

    

     

    
      	 	
              (b)

            	
              competitors
                of the Corporation and the Business are located in countries around
                the
                world;

            

    

     

    
      	 	
              (c)

            	
              in
                order to protect the Corporation adequately, any enjoinder of competition
                would have to
                apply world wide;

            

    

     

    
      	 	
              (d)

            	
              during
                the course of your employment by the Corporation, both before and
                after
                the Effective
                Date, on behalf of the Corporation, you have acquired and will acquire
                knowledge
                of, and you have come into contact with, initiated and established
                relationships
                with and will come into contact with, initiate and establish relationships
                with, both existing and new clients, customers, suppliers, principals,
                contacts and prospects of the
                Corporation, and that in some circumstances you have been or may
                well
                become the senior or sole representative of the Corporation dealing
                with
                such persons; and

            

    

     

    
      	 	
              (e)

            	
              in
                light of the foregoing, the provisions of Section 24 (Restrictive
                Covenant) below are reasonable
                and necessary for the proper protection of the business, property
                and
                goodwill
                of the Corporation and the
                Business.

            

    

     

    
      	
              24.

            	
              Restrictive
                Covenant.
                Subject to the exceptions set out in Schedule E attached hereto,
                you agree
                that
                you will not, either alone or in partnership or in conjunction with
                any
                person, firm, company, corporation,
                syndicate, association or any other entity or group, whether as principal,
                agent, employee,
                director, officer, shareholder, consultant or in any capacity or
                manner
                whatsoever, whether
                directly or indirectly, for the Term of Employment and continuing
                for a
                period of 6 months from
                the lawful termination of your employment, regardless of the reason
                for
                such termination:

            

    

     

     
      (a)        carry
      on or be engaged in,
      concerned with or interested in, or advise, invest in or give financial
      assistance to, any business, enterprise or undertaking that:

     

       (i)
      is involved in
      the Business or in the sale, distribution, development or supply of any
      product or service that is competitive with the Business or any product or
      service
      of the Business; or

     

     (ii)
      competes with the
      Corporation with respect to any aspect of the Business;

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -10-

     

    provided,
      however, that the foregoing will not prohibit you from acquiring, solely as
      an
investment
      and through market purchases, securities of any such enterprise or undertaking
      which are publicly traded, so long as you are not part of any control group
      of
      such entity and such securities, which if converted, do not constitute more
      than
      5% of the outstanding voting power of that entity;

     

    
      	 	
              (b)

            	
              solicit,
                agree to be employed by, or agree to provide services to any person,
                firm,
                corporation
                or other entity that was a client, customer, supplier, principal,
                shareholder, investor,
                collaborator, strategic partner, licensee, contact or prospect of
                the
                Corporation during
                the time of your employment with the Corporation, whether before
                or after
                the Effective Date, for any business purpose that is competitive
                with the
                Business or any product
                or service of the Business; or

            

    

     

    
      	 	
              (c)

            	
              divert,
                entice or take away from the Corporation or attempt to do so or solicit
                for the purpose
                of doing so, any business of the Corporation, or any person, firm,
                corporation or other
                entity that was an employee, client, customer, supplier, principal,
                shareholder, investor,
                collaborator, strategic partner, licensee, contact or prospect of
                the
                Corporation during
                the time of your employment with the Corporation, whether before
                or after
                the Effective
                Date.

            

    

     

    
      	
              25.

            	
              Remedies.
                You acknowledge and agree that any breach or threatened breach of
                any of
                the provisions
                of Section 11 (Compliance with Insider Trading Guidelines and
                Restrictions), Section 14
                (Service to Employer), Section 20 (Confidentiality and Assignment
                of
                Inventions), Section 21 (Disclosure of Conflicts of Interest), Section
                22
                (Avoidance of Conflicts of Interest) or Section 24 (Restrictive
                Covenant) could cause irreparable damage to the Corporation or its
                partners, subsidiaries
                or affiliates, that such harm could not be adequately compensated
                by the
                Corporation's
                recovery of monetary damages, and that in the event of a breach or
                threatened breach
                thereof, the Corporation shall have the right to seek an injunction,
                specific performance or other
                equitable relief as well as any equitable accounting of all your
                profits
                or benefits arising out of
                any such breach. It is further acknowledged and agreed that the remedies
                of the Corporation specified in this Section 25 are in addition to
                and not
                in substitution for any rights or remedies of the Corporation at
                law or in
                equity and that all such rights and remedies are cumulative and not
                alternative
                and that the Corporation may have recourse to any one or more of
                its
                available rights or
                remedies as it shall see fit.

            

    

     

    
      	
              26.

            	
              Binding
                Effect.
                This Agreement shall be binding upon and inure to the benefit of
                the
                Corporation and
                its successors and assigns. Your rights and obligations contained
                in this
                Agreement are personal
                and such rights, benefits and obligations shall not be voluntarily
                or
                involuntarily assigned,
                alienated or transferred, whether by operation of law or otherwise,
                without the prior written
                consent of the Corporation. This Agreement shall otherwise be binding
                upon
                and inure to the
                benefit of your personal or legal representatives, executors,
                administrators, successors, heirs, distributees, devisees, legatees
                and
                permitted assigns.

            

    

     

    
      	
              27.

            	
              Agreement
                Confidential.
                Both parties shall keep the terms and conditions of this Agreement
                confidential
                except as may be required to enforce any provision of this Agreement
                or as
                may otherwise
                be required by any law, regulation or other regulatory
                requirement.

            

    

     

    
      	
              28.

            	
              Governing
                Law.
                This Agreement shall be governed by and interpreted in accordance
                with the
                laws of the Province of British Columbia and applicable laws of Canada
                and
                the parties hereto attorn
                to the exclusive jurisdiction of the provincial and federal courts
                of such
                province.

            

    

     

    
      	
              29.

            	
              Exercise
                of Functions.
                The rights of the Corporation as provided in this Agreement may be
                exercised
                on behalf of the Corporation only by the
                Board.

            

    

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -11-

     

    
      	
              30.

            	
              Entire
                Agreement.
                The terms and conditions of this Agreement are in addition to and
                not in
                substitution for the obligations, duties and responsibilities imposed
                by
                law on employers and employees
                of corporations generally, and you and the Corporation agree to comply
                with such obligations,
                duties and responsibilities. Except as otherwise provided in this
                Agreement, this Agreement
                constitutes the entire agreement between the parties with respect
                to the
                subject matter
                hereof, and may only be varied by further written agreement signed
                by you
                and the Corporation.
                This Agreement supersedes any previous communications, understandings
                and
                agreements
                between you and the Corporation regarding your employment. It is
                acknowledged and
                agreed that this Agreement is mutually beneficial and is entered
                into for
                fresh and valuable consideration
                with the intent that it shall constitute a legally binding
                agreement.

            

    

     

    
      	
              31.

            	
              Further
                Assurances.
                The parties will execute and deliver to each other such further
                instruments and assurances and do such further acts as may be required
                to
                give effect to this Agreement.

            

    

     

    
      	
              32.

            	
              Surviving
                Obligations.
                Your obligations and covenants under Section 20 (Confidentiality
                and
                Assignment
                of Inventions), Section 24 (Restrictive Covenant) and Section 25
                (Remedies) shall survive
                the termination of this Agreement.

            

    

     

    
      	
              33.

            	
              Independent
                Legal Advice.
                You hereby acknowledge that you have obtained or have had an opportunity
                to obtain independent legal advice in connection with this Agreement,
                and
                further acknowledge
                that you have read, understand, and agree to be bound by all of the
                terms
                and conditions
                contained herein.

            

    

     

    
      	
              34.

            	
              Notice.
                All notices and other communications that are required or permitted
                by
                this Agreement must
                be in writing and shall be hand delivered or sent by express delivery
                service or certified or registered mail, postage prepaid, or by facsimile
                transmission (with written confirmation copy by registered
                mail) to the parties at the addresses indicated
                below.

            

    

     

    If
      to Aspreva:

     

    Aspreva
      Pharmaceuticals Corporation 

    Farris,
      Vaughan, Wills & Murphy 

    26th
      Floor, 700 West Georgia Street 

    Vancouver,
      BC.V7Y1B3

     

    Attn:
      R. Hector MacKay-Dunn

     

    If
      to Name:
      Richard
      Jones

    19,
      Chlupfgasse 

    Bassersdorf
      CH Zurich 8303

     

    Any
      such notice shall be deemed to have been received on the earlier of the date
      actually received or the date
      five (5) days after the same was posted or sent. Either party may change its
      address or its facsimile number
      by giving the other party written notice, delivered in accordance with this
      Section.

     

    
      	
              35.

            	
              Severabilitv.
                If any provision of this Agreement or any part thereof shall for
                any
                reason be held to be
                invalid or unenforceable in any respect, then such invalid or
                unenforceable provision or part shall
                be severable and severed from this Agreement and the other provisions
                of
                this Agreement shall remain in effect and be construed as if such
                invalid
                or unenforceable provision or part had never
                been contained herein.

            

    

     

    
      	
              36.

            	
              Waiver.
                Any waiver of any breach or default under this Agreement shall only
                be
                effective if in writing
                signed by the party against whom the waiver is sought to be enforced,
                and
                no waiver shall be
                implied by any other act or conduct or by any indulgence, delay or
                omission. Any waiver shall only apply to the specific matter waived
                and
                only in the specific instance in which it is
                waived.

            

    

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    -
      12-

     

    37.    Counterparts'.
      This
      Agreement may be executed in any number of counterparts, each of which so
executed
      shall be deemed to be an original, and such counterparts will together
      constitute but one
      Agreement.

     

    If
      you
      accept and agree to the foregoing, please confirm your acceptance and agreement
      by signing the enclosed duplicate copy of this letter where indicated below
      and
      by returning it to us. You are urged to consider
      fully all the above terms and conditions and to obtain independent legal advice
      Or any other advice
      you feel is necessary before you execute this agreement.

     

     

     

                                                                            Yours
      truly,

    

     

                                                                             ASPREVA
      PHARMACEUTICALS
      CORPORATION

     

    

     

                                                                            
By:/s/
      Noel
      Hall                                                     

                                                                                 
Authorized
      Signatory

    

    Accepted
      and agreed to by Richard Jones as of the 1st day of November
      2005.

    

    

    /s/
      Richard Jones                                        

    Richard
      Jones

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    SCHEDULE
      C

     

    CONFIDENTIALITY
      AGREEMENT AND 

    ASSIGNMENT
      OF INVENTIONS

     

    ASPREVA
      PHARMACEUTICALS CORPORATION

     

    PRIVATE
      AND CONFIDENTIAL

     

    November
      1,2005

    

    Richard
      Jones 

    19,
      Chlupfgasse 

    Bassersdorf
      CH 8303

     

    Dear
      Richard:

     

    The
      purpose of this letter is to confirm and record the terms of the agreement
      (the
"Agreement")
      between
      you
      and
      Aspreva Pharmaceuticals Corporation ("Aspreva")
      concerning
      the terms on which you will (i) receive
      from and disclose to Aspreva proprietary and confidential information; (ii)
      agree to keep the information
      confidential, to protect it from disclosure and to use it only in accordance
      with the terms of this Agreement;
      and (iii) assign to Aspreva all rights, including any ownership interest which
      may arise in all inventions
      and intellectual property developed or disclosed by you over the course of
      your
      work during your employment with Aspreva. The effective date ("Effective
      Date") of
      this
      Agreement is the date that you start or started working at Aspreva, as indicated
      in the employment agreement between you and Aspreva
      dated as of 1st
      March,
      2006.

     

    In
      consideration of the offer of employment by Aspreva and the payment by Aspreva
      to you of the sum of CDN$1.00 and other good and valuable consideration, the
      receipt and sufficiency of which is hereby acknowledged,
      you and Aspreva hereby agree as follows:

     

    INTERPRETATION

     

    1.2               Definitions.
      In
      this
      Agreement:

     

    (a)        "Confidential
      Information", subject
      to the exemptions set out in Section 2.8, shall mean any
      information relating to Aspreva's Business (as hereinafter defined), whether
      or
      not conceived, originated, discovered, or developed in whole or in part by
      you,
      that is not generally known to the public or to other persons who are not bound
      by obligations of confidentiality
      and:

     

    (i)     from
      which
      Aspreva derives economic value, actual or potential, from the information
      not being generally known; or

     

    (ii)     in
      respect of
      which Aspreva otherwise has a legitimate interest in maintaining secrecy;

     

    and
      which, without limiting the generality of the foregoing, shall
      include;

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

     

    -2-

     

    (iii)         all
      proprietary
      information licensed to, acquired, used or developed by Aspreva in its
      search and development activities including but not restricted to the
development
      and commercialization of drugs for rare diseases and conditions and
      orphan drugs as defined by the U.S. Orphan
      Drug Act, other
      scientific strategies
      and concepts, designs, know-how, information, material, formulas, processes,
      research data and proprietary rights in the nature of copyrights, patents,
      trademarks, licenses and industrial designs;

     

    (iv)         all
      information
      relating to Aspreva's Business, and to all other aspects of Aspreva's
      structure, personnel, and operations, including financial, clinical,
regulatory,
      marketing, advertising and commercial information and strategies, customer
      lists, compilations, agreements and contractual records and correspondence;
      programs, devices, concepts, inventions, designs, methods, processes, data,
      know-how, unique combinations of separate items that is not generally
      known and items provided or disclosed to Aspreva by third parties subject
      to restrictions on use or disclosure;

     

    (v)         all
      know-how relating
      to Aspreva's Business including., all biological, chemical, pharmacological,
      toxicological, pharmaceutical, physical and analytical, clinical, safety,
      manufacturing and quality control data and information, and all applications,
      registrations, licenses, authorizations, approvals and correspondence
      submitted to regulatory authorities;

     

    (vi)         all
      information
      relating to the businesses of competitors of Aspreva including information
      relating to competitors' research and development, intellectual property,
      operations, financial, clinical, regulatory, marketing, advertising and
commercial
      strategies, that is not generally known;

     

    (vii)         all
      information
      provided by Aspreva's agents, consultants, lawyers, contractors, licensors
      or licensees to Aspreva and relating to Aspreva's Business; and

     

    (viii)         all
      information
      relating to your compensation and benefits, including your salary, vacation,
      stock options, rights to continuing education, perquisites, severance
notice,
      rights on termination and all other compensation and benefits, except that
      you
      shall be entitled to disclose such information to your bankers, advisors,
agents,
      consultants and other third parties who have a duty of confidence to you
and
      who
      have a need to know such information in order to provide advice, products
      or services to you.

     

    
      	
              (b)

            	
              "Inventions"
                shall
                mean any and all discoveries, developments, enhancements, improvements,
                concepts, formulas, processes, ideas, writings, whether or not reduced
                to
                practice,
                industrial and other designs, patents, patent applications, provisional
                patent applications,
                continuations, continuations-in-part, substitutions, divisionals,
                reissues, renewals,
                re-examinations, extensions, supplementary protection certificates
                or the
                like, trade
                secrets or utility models, copyrights and other forms - of intellectual
                property including
                all applications, registrations and related foreign applications
                filed and
                registrations granted thereon.

            

    

     

    
      	
              (c)

            	
              "Work
                Product" shall
                mean any and all Inventions and possible Inventions relating to
                Aspreva's
                Business resulting from any work performed by you for Aspreva that
                you may
                invent
                or co-invent during your involvement in any capacity with Aspreva,
                except
                those Inventions
                invented by you entirely on your own time that do not relate to Aspreva's
                Business
                or do not derive from any equipment, supplies, facilities, Confidential
                Information
                or other information, gained, directly or indirectly, by you from
                or
                through your involvement in any capacity with
                Aspreva.

            

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    -3-

     

    (d)         "Aspreva's
      Business"
shall
      mean the businesses actually carried on by Aspreva, directly
      or indirectly, whether under an agreement with or in collaboration with, any
      other party
      including but not exclusively, the development and commercialization of drugs
      for rare
      diseases and conditions and orphan drugs as defined by the U.S. Orphan
      Drug Act.

     

    2.                 
      CONFIDENTIALITY

     

    2.1                
      Basic
      Obligation of Confidentiality. You
      hereby acknowledge and agree that in the course
      of your involvement with Aspreva, Aspreva may disclose to you or you may
      otherwise have access
      or be exposed to Confidential Information. Aspreva hereby agrees to provide
      such
      access to you and you agree to receive and hold all Confidential Information
      on
      the terms and conditions set out in this Agreement.
      Except as set out in this Agreement, you will keep strictly confidential all
      Confidential Information
      and all other information belonging to Aspreva that you acquire, observe or
      are
      informed of, directly
      or indirectly, in connection with your involvement, in any capacity, with
      Aspreva.

     

    2.2                 
      Fiduciary
      Capacity. You
      will be and act toward Aspreva as a fiduciary in respect of the Confidential
      Information.

     

    2.3                  Non-disclosure.
      Unless
      Aspreva first gives you written permission to do so under Section
      2.7 of this Agreement, you will not at any time, either during or after your
      involvement in any capacity
      with Aspreva;

     

    (a)     use
      or
      copy Confidential Information or your recollections thereof;

     

    
      	 	
              (b)

            	
              publish
                or disclose Confidential Information or your recollections thereof
                to any
                person other
                than to employees of Aspreva who have a need to know such Confidential
                Information
                for their work for Aspreva;

            

    

     

    
      	 	
              (c)

            	
              permit
                or cause any Confidential Information to be used, copied, published,
                disclosed, translated
                or adapted except as otherwise expressly permitted by this
                Agreement;

            

    

     

    
      	 	
              (d)

            	
              permit
                or cause any Confidential Information to be stored off the premises
                of
                Aspreva, including
                permitting or causing such Information to be stored in electronic
                format
                on personal
                computers, except in accordance with written procedures of Aspreva,
                as
                amended
                from time to time in writing; or

            

    

     

    
      	 	
              (e)

            	
              communicate
                the Confidential Information or your recollections thereof to another
                employee
                of Aspreva in a public place or using methods of communication that
                are
                capable of being intercepted (such as unencrypted messages using
                the
                internet or cellular
                phones) or overheard, without the written permission of
                Aspreva.

            

    

    

    2.4               Taking
      Precautions. You
      will take all reasonable precautions necessary or prudent to prevent
      material in your possession or control that contains or refers to Confidential
      Information from being
      discovered, used or copied by third parties.

     

    2.5                Aspreva's
      Ownership of Confidential Information. As
      between you and Aspreva, Aspreva
      shall own all right, title and interest in and to the Confidential Information,
      whether or not created or developed by you.

     

    2.6                Control
      of Confidential Information and Return of Information. All
      physical materials produced or prepared by you containing Confidential
      Information, including, without limitation, biological material,
      chemical entities, test results, notes of experiments, computer files,
      photographs, x-ray film, designs,
      devices, formulas, memoranda, drawings, plans, prototypes, samples, accounts,
      reports, financial
      statements, estimates and materials prepared in the course of your
      responsibilities to or for the benefit
      of Aspreva, shall belong to Aspreva, and you will promptly turn over to
      Aspreva's possession

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    -4-

     

    every
      original and copy of any and all such items in your possession or control upon
      request by Aspreva. You
      shall not permit or cause any physical materials to be stored off the premises
      of Aspreva, unless in accordance with written procedures of Aspreva, as amended
      from time to time in writing. You shall not transfer
      any biological material to another person outside of Aspreva, unless a material
      transfer agreement
      has been signed by both Aspreva and the other party. You shall not accept any
      biological material
      from another person outside of Aspreva, unless in accordance with written
      procedures of Aspreva,
      as amended from time to time in writing.

     

    2.7            Purpose
      of Use. You
      will use Confidential Information only for purposes authorised or directed
      by Aspreva.

     

    2.8            Exemptions.
      Your
      obligation of confidentiality under this Agreement will not apply to any
of
      the
      following:

    

     

    
      	 	
              (a)

            	
              information
                that is already known to you, though not due to a prior disclosure
                by
                Aspreva or
                by a person who obtained knowledge of the information, directly or
                indirectly, from Aspreva;

            

    

     

    
      	 	
              (b)

            	
              information
                disclosed to you by another person who is not obliged to maintain
                the
                confidentiality
                of that information and who did not obtain knowledge of the information,
                directly
                or indirectly, from Aspreva;

            

    

     

    
      	 	
              (c)

            	
              information
                that is developed by you independently of Confidential Information
                received from
                Aspreva and such independent development can be documented by
                you;

            

    

     

      
      (d)      
other
      particular information or
      material which Aspreva expressly exempts by written instrument
      signed by Aspreva;

     

    (e)       information
      or material that is in the public domain through no fault of your own;
      and

     

    
      	 	
              (f)

            	
              information
                or material that you are obligated by law to disclose, to the extent
                of
                such obligation,
                provided that:

            

    

     

    (i)         
in
      the event
      that you are required to disclose such information or material, then,
as
      soon
      as you become aware of this obligation to disclose, you will provide Aspreva
      with prompt written notice so that Aspreva may seek a protective order
or
      other appropriate remedy and/or waive compliance with the provisions of this
      Agreement;

     

    (ii)         if
      Aspreva agrees that the disclosure
      is required by law, it will give you written authorization
      to disclose the information for the required purposes only;

     

    (iii)        
if
      Aspreva does not
      agree that the disclosure is required by law, this Agreement will
      continue to apply, except to the extent that a Court of competent jurisdiction
      orders
      otherwise; and

     

    (iv)        
if
      a protective
      order or other remedy is not obtained or if compliance with this Agreement
      is
      waived, you will furnish only that portion of the Confidential Information
      that
      is legally required and will exercise all reasonable efforts to obtain
      confidential treatment of such Confidential Information.

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    -5-

     

    3.            ASSIGNMENT
      OF INTELLECTUAL PROPERTY RIGHTS

     

    3.1           Notice
      of Invention. You
      agree to promptly and fully inform Aspreva of all your Work Product,
      whether or not patentable, throughout the course of your involvement, in any
      capacity, with Aspreva,
      whether or not developed before or after your execution of this Agreement.
      On
      your ceasing to be
      employed by Aspreva for any reason whatsoever, you will immediately deliver
      up
      to Aspreva all of your-
      Work Product. You further agree that all of your Work Product shall at all
      times
      be the Confidential Information
      of Aspreva.

     

    3.2           
Assignment
      of Rights. Subject
      only to those exceptions set out in Exhibit
      A hereto,
      you
      will assign, and do hereby assign, to Aspreva or, at the option of Aspreva
      and
      upon notice from Aspreva,
      to Aspreva's designee, your entire right, title and interest in and to all
      of
      your Work Product during
      your involvement, in any capacity, with Aspreva and all other rights and
      interests of a proprietary nature
      in and associated with your Work Product, including all patents, patent
      applications filed and other registrations
      granted thereon. To the extent that you retain or acquire legal title to any
      such rights and interests,
      you hereby declare and confirm that such legal title is and will be held by
      you
      only as trustee and
      agent for Aspreva. You agree that Aspreva's rights hereunder shall attach to
      all
      of your Work Product,
      notwithstanding that it may be perfected or reduced to specific form after
      you
      have terminated your relationship with Aspreva. You further agree that Aspreva's
      rights hereunder are worldwide rights and
      are
      not limited to Canada, but shall extend to every country of the
      world.

     

    3.3            
      Moral
      Rights. Without
      limiting the foregoing, you irrevocably waive any and all moral rights
      arising under the Copyright
      Act (Canada),
      as amended, or any successor legislation of similar force and
      effect or similar legislation in other applicable jurisdictions or at common
      law
      that you may have with respect
      to your Work Product, and agree never to assert any moral rights which you
      may
      have in your Work
      Product, including, without limitation, the right to the integrity of such
      Work
      Product, the right to be associated
      with the Work Product, the right to restrain or claim damages for any
      distortion, mutilation or other
      modification or enhancement of the Work Product and the right to restrain the
      use or reproduction of the Work Product in any context and in connection with
      any product, service, cause or institution, and you further
      confirm that Aspreva may use or alter any such Work Product as Aspreva sees
      fits
      in its absolute discretion.

     

    3.4            
Goodwill.
      You
      hereby agree that all goodwill you have established or may establish with .
      clients,
      customers, suppliers, principals, shareholders, investors, collaborators,
      strategic partners, licensees,
      contacts or prospects of Aspreva relating to the business or affairs of Aspreva
      (or of its partners,
      subsidiaries or affiliates), both before and after the Effective Date, shall,
      as
      between you and Aspreva, be and remain the property of Aspreva exclusively,
      for
      Aspreva to use, alter, vary, adapt and exploit
      as Aspreva shall determine in its discretion.

     

    3.5            
      Assistance.
      You
      hereby agree to reasonably assist Aspreva, at Aspreva's request and expense,
      in:

     

    
      	 	
              (a)

            	
              making
                patent applications for your Work Product, including instructions
                to
                lawyers and/or patent
                agents as to the characteristics of your Work Product in sufficient
                detail
                to enable the
                preparation of a suitable patent specification, to execute all formal
                documentation incidental to an application for letters patent and
                to
                execute assignment documents in favour
                of Aspreva for such applications;

            

    

     

    
      	 	
              (b)

            	
              making
                applications for all other forms of intellectual property registration
                relating to your Work
                Product;

            

    

     

    
      	 	
              (c)

            	
              prosecuting
                and maintaining the patent applications and other intellectual property
                relating
                to your Work Product; and

            

    

     

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    -6-

     

    (d)       registering,
      maintaining
      and enforcing the patents and other intellectual property registrations
      relating to your Work Product.

     

    3.6             Assistance
      with Proceedings. You
      further agree to reasonably assist Aspreva, at Aspreva's
      request and expense, in connection with any defence to an allegation of
      infringement of another
      person's intellectual property rights, claim of invalidity of another person's'
      intellectual property rights, opposition to, or intervention regarding, an
      application for letters patent, copyright or trademark or other proceedings
      relating to intellectual property or applications for registration
      thereof.

     

    4.            
      GENERAL

     

    4.1            Term
      and Duration of Obligation. The
      term of this Agreement is from the Effective Date
      and terminates on the date that you are no longer working at or for Aspreva.
      Except as otherwise agreed
      in a written instrument signed by Aspreva, Article 2 shall survive the
      termination of this Agreement,
      including your obligations of confidentiality and to return Confidential
      Information, and shall endure,
      with respect to each item of Confidential Information, for so long as those
      items fall within the definition
      of Confidential Information. Sections 1.2, 3.2, 3.3, 3.4, 3.5, 3.6, 4.1, 4.2,
      4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 4.11, 4.12 and 4.13 shall also survive
      the
      termination of this Agreement.

     

    4.2            Binding
      Nature of Agreement. This
      Agreement is not assignable by you. You agree that
      this Agreement shall be binding upon your heirs and estate.

     

    4.3            Non-Competition.
      While
      you are an employee of Aspreva, you will not provide services to or enter into
      a
      contract of employment or service in any capacity for any business which is
      in
      any way competitive
      with Aspreva's Business without the prior written consent of
      Aspreva.

     

    4.4            No
      Conflicting Obligations. You
      represent and warrant that you will not use or disclose to other persons at
      Aspreva information that (i) constitutes a trade secret of persons other than
      Aspreva during
      your employment at Aspreva, or (ii) which is confidential information owned
      by
      another person. You
      represent and warrant that you have no agreements with or obligations to others
      with respect to the matters
      covered by this Agreement or concerning the Confidential Information that are
      in
      conflict with anything
      in this Agreement.

     

    4.5            Equitable
      Remedies. You
      acknowledge and agree that a breach by you of any of your obligations
      under this Agreement would result in damages to Aspreva that could not be
      adequately compensated
      by monetary award. Accordingly, in the event of any such breach by you, in
      addition to all other remedies available to Aspreva at law or in equity, Aspreva
      shall be entitled as a matter of right to apply
      to a court of competent jurisdiction for such relief by way of restraining
      order, injunction, decree or otherwise,
      as may be appropriate to ensure compliance with the provisions of this
      Agreement, without having
      to prove damages to the court.

     

    4.6            Publicity.
      You
      shall not, without the prior written consent of Aspreva, make or give any
public
      announcements, press releases or statements to the public or the press regarding
      your Work Product
      or any Confidential Information.

     

    4.7            Severability.
      If
      any
      covenant or provision of this Agreement or of a section of this Agreement
      is determined by a court of competent jurisdiction to be void or unenforceable
      in whole or in part,
      then such void or unenforceable covenant or provision shall not affect or impair
      the enforceability or validity
      of the balance of the section or any other covenant or provision.

     

    4.8            Time
      of Essence/No Waiver. Time
      is
      of the essence hereof and no waiver, delay, indulgence,
      or failure to act by Aspreva regarding any particular default or omission by
      you
      shall affect or impair
      any of Aspreva's rights or remedies regarding that or any subsequent default
      or
      omission that is not
      expressly waived in writing, and in all events time shall continue to be of
      the
      essence without the necessity
      of specific reinstatement.

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    -
      7-

     

    4.9            Further
      Assurances. The
      parties will execute and deliver to each other such further instruments
      and assurances and do such further acts as may be required to give effect to
      this Agreement.

     

    4.10            Notices.
      All
      notices and other communications that are required or permitted by this
Agreement
      must be in writing and shall be hand delivered or sent by express delivery
      service or certified or
      registered mail,, postage prepaid, or by facsimile transmission (with written
      confirmation copy by registered
      mail) to the parties at the addresses indicated below.

     

    If
      to Aspreva:

     

    Aspreva
      Pharmaceuticals Corporation 

    Farris,
      Vaughan, Wills & Murphy 

    26th
      Floor, 700 West Georgia Street 

    Vancouver,
      BC V7Y1B3

     

    Attn:
      R. Hector MacKay-Dunn

     

    If
      to Richard Jones:

    

    Richard
      Jones 

    19,
      Chlupfgasse 

    Bassersdorf
      CH 8303

     

    Any
      such notice shall be deemed to have been received on the earlier of the date
      actually received or the date.five (5) days after the same was posted or sent.
      Either party may change its address or its facsimile number
      by giving the other party written notice, delivered in accordance with this
      Section.

     

    4.11            Amendment.
      No
      amendment, modification, supplement or other purported alteration of
this
      Agreement shall be binding unless it is in writing and signed by you and by
      Aspreva.

     

    4.12            Entire
      Agreement. This
      Agreement supersedes all previous dealings, understandings, .
      and
      expectations of' the parties and constitutes the whole agreement with respect
      to
      the matters contemplated
      hereby, and there are no representations, warranties, conditions or collateral
      agreements between the parties with respect to such transactions except as
      expressly set out herein.

     

    4.13            Governing
      Law. This
      Agreement shall be governed by and interpreted in accordance with
      the laws of the Province of British Columbia and applicable laws of Canada
      and
      the parties hereto attorn
      to the exclusive jurisdiction of the provincial and federal courts of such
      province.

     

    4.14            Independent
      Legal Advice. You
      hereby acknowledge that you have obtained or have had
      an
      opportunity to obtain independent legal advice in connection with this
      Agreement, and further acknowledge
      that you have read, understand, and agree to be bound by all of the terms and
      conditions contained
      herein.

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    -
      8-

     

    Acceptance

     

    If
      the
      foregoing terms and conditions are acceptable to you, please indicate your
      acceptance
      of and agreement to the terms and conditions of this Agreement by signing below
      on this letter
      and on the enclosed copy of this letter in the space provided and by returning
      the enclosed copy so executed
      to us. Your execution and delivery to Aspreva of the enclosed copy of this
      letter will create a binding
      agreement between us.

     

    Thank
      you for your cooperation in this matter.

    Yours
      truly,

     

    ASPREVA
      PHARMACEUTICALS CORPORATION

     

    By:/s/
      Noel
      Hall                                                     

        
Noel
      Hall

     

    Accepted
      and agreed as of the 1st day of November 2005.

     

    
      	 	 	/s/
              Richard Jones
	
              Witness
                Signature

            	 	
              Signature
                of Richard Jones

            

    

     

    __________________________________________________________________________________

    Witness
      Name 

     

    
      
        __________________________________________________________________________________
Occupation

    

     

    
      __________________________________________________________________________________
Address

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    SCHEDULE
      D 

    BUSINESS
      OF THE COMPANY

     

    The
      business of the Corporation shall mean the business actually carried on by
      the
      Corporation, directly or
      indirectly, whether under an agreement with or in collaboration with any other
      party including, but not limited to the development and commercialization of
      drugs for rare diseases and conditions and orphan drugs
      as defined by the U.S. Orphan
      Drug Act.

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    SCHEDULE
      E

     

    EXCEPTION
      TO RESTRICTIVE COVENANT

     

    None

     

     

    

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

     

    EXHIBIT
      A

     

    EXCLUSION
      FROM WORK PRODUCT

     

    None

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]